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Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental pollutants 
made of fused aromatic rings. The improper disposal of petrochemicals is a major source 
of PAHs in the environment. They are generally recalcitrant due to their stability and poor 
water solubility. Degradation of PAHs by bacteria and other microorganisms is one way to 
remove PAHs from contaminated environments. Mycobacterium vanbaalenii PYR-1 is the 
first identified bacterium with the ability to completely degrade pyrene. In addition, M. 
vanbaalenni PYR-1 can degrade a variety of PAHs and, in this regard, is the most 
nutritionally versatile bacteria isolated so far. The degradation of PAHs by M. vanbaalenni 
PYR-1 has been extensively studied with many proposed avenues leading to useful cellular 
intermediates. However, there is very little biochemical evidence for many of these 
pathways.   
 
The degradative pathways for naphthalene, phenanthrene, pyrene, and fluoranthene 
were examined. Within the naphthalene catabolic pathway, no enzymes have been assigned 
to the ring-opening of 1,2-dihydroxynaphthalene or the hydration and retro-aldol cleavage 
v 
of trans-o-hydroxybenzylidenepyruvate. Within the phenanthrene catabolic pathway, 1-
hydroxy-2-naphtoate and trans-o-carboxybenzylidenepyruvate are thought to be processed 
by the enzymes designated PhdI and PhdJ, respectively. The results show that PhdI ring-
opens 1-hydroxy-2-naphthoate but not 1,2-dihydroxynaphthalene. The hydratase-aldolase 
PhdJ processes both trans-o-hydroxybenzylidenepyruvate and trans-o-
carboxybenzylidenepyruvate but prefers trans-o-carboxybenzylidenepyruvate. Ring-
opening of both 3,4-dihydroxyphenanthrene and 9,10-dihydroxyphenanthrene, 
intermediates in the phenanthrene catabolic pathway, have previously been assigned to 
PhdF. However, the results show that PhdF catalyzes the ring-opening of 3,4-
dihydroxyphenanthrene but not 9,10-dihydroxyphenanthrene. We also show that the 
product of the PhdF-catalyzed reaction using 3,4-dihydroxyphenanthrene is processed by 
PhdG, the enzyme proposed to do this reaction. Finally, PhdF was reported to catalyze all 
ring-opening reactions in the upper catabolic pathways for pyrene and fluoranthene. We 
find that PhdF does not catalyze any of these proposed reactions in the pyrene pathway and 
investigations in the fluoranthene pathway are ongoing.  
 
The sum of our observations clarifies the reaction pathways for the degradation of 
naphthalene, phenanthrene, pyrene, and fluoranthene in M. vanbaalenii PYR-1. This work 
sets the stage for detailed mechanistic studies of the individual enzymes. This knowledge, 
combined with the considerable body of literature on PAH degradation pathways, could 
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Chapter 1: Introduction 
1.1 Pollutants  
a. General 
A pollutant is defined as a harmful substance with an unnatural presence or elevated 
concentration in an environment or organism (Mathew, 2017). Pollutants impact all environments, 
including air through greenhouse gases and particulate matter, soil through pesticide use, improper 
disposal of toxic chemicals, and non-biodegradable material, and water through oil spills and 
runoff from contaminated soils (Gavrilescu, 2010). The pollutants with the highest impact are 
consequences of an increase over the last century in human activities such as urbanization, 
transportation, industry, and agriculture (Gavrilescu, 2010). By 2000, the global chemical 
production reached 400 million tons per year, with 50% of these chemicals considered 
environmentally harmful (World Wide Fund, 2018). The toxic, persistent, and pervasive 
characteristics of pollutants can originate from the parent pollutant or from a byproduct during 
pollutant degradation (Mathew, 2017). The Stockholm Convention of the United Nations 
Environment Program labels the most toxic of pollutants as persistent organic pollutants (POPs) 
(UNEP, 2001). POPs are defined as organic substances that are persistent in the environment by 
remaining intact for many years, capable of traveling long ranges through air, soil, or water, 
capable of bioaccumulation, and toxic to humans and wildlife (UNEP, 2001). A list of these 
compounds can be found in Table 1.1 (Megson, 2016). Unfortunately, pollution remains a threat 
due to the lack of risk assessment for many human processes and the lack of proper and adequate 
prevention or remediation methods (Gavrilescu, 2015).   
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Table 1.1: POPs list from the Stockholm convention (adapted from Megson, 2016). 
 
b. Polycyclic Aromatic Hydrocarbons 
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous, carcinogenic pollutants made up 
of fused aromatic rings (Kaushik, 2006). PAHs are created through incomplete combustion of fuels 
such as coal, petroleum, oil, and wood. Natural exposure occurs through forest fires, oil seeps, and 
volcanic eruptions, but most environmental exposure is the result of human processes (Kaushik, 










Added May 2009 Hexachlorocyclohexane Pentchlorobenzene
Chlordecone Tetrabromodiphenyl ether
Hexabromobiphenyl Pentabromodiphenyl ether
Hexabromodihpenyl ether Perfluorooctanesulfonic acid
Heptabromodiphenyl ether Perfluorooctanesulfonyl fluoride
Lindane
Added May 2011 Endosulfan
Added May 2013 Hexabromocyclododecane
Added May 2015 Hexachlorobutadiene
Pentachlorophenol
Polychlorinated naphthalenes






Table 1.2: Industrial activities associated with PAH production (adapted from Duan, 2015). 
 
Human exposure occurs primarily through inhalation of automobile exhaust, tobacco 
smoke, wood smoke, and consumption of charcoal-broiled foods or foods that have 
bioaccumulated the toxin (U.D.H.H., 1995). PAHs share characteristics with POPs and the two 
pollutant groups are often jointly monitored and regulated (EPA POP; Farrington, 2014). PAHs 
account for 16 of the 129 compounds on the EPA’s priority pollutant list subject to regulation and 
testing (EPA Priority).  A list of the PAHs on the priority pollutant list is given in Table 1.3 
(Louvado, 2015). Of the 1408 waste sites that are classified as hazardous and targeted for long-




Industrial Activities Predominant PAHs
Gasification/liquefaction of fossil fuels Fluoranthene, pyrene, chrysene, benzo(a)pyrene
Coke production Anthracene, phenanthrene, benzo(a)pyrene
Catalytic cracking Fluoranthene, pyrene, benzo(b)fluoranthene,
benzo(k)fluoranthene, thiophene compounds
Carbon-black production/use Fluoranthene, benzo(a)pyrene
Asphalt production/use Fluoranthene, pyrene, chrysene, benzo(a)pyrene
Coal-tar/coal-tar-pitch production/use Fluoranthene, phenanthrene, pyrene
Crude oil refining/distillation Pyrene, benzo(a)pyrene
Wood-preservative/combustion Fluoranthene, benzo(a)pyrene
Fuel/oil storage, transportation, Fluoranthene, pyrene, benzo(b)fluoranthene, 
processing, use, disposal benzo(k)fluoranthene, thiophene compounds
Open burning Phenanthrene, anthracene






Table 1.3: PAHs on the EPA’s priority pollutant list with estimated half-lives in soil (Adapted from 





















EPA Priority PAH EPA Priority PAH
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PAHs with 3 or fewer rings are considered low molecular weight (LMW) while those with 
4 or more rings are considered high molecular weight (HMW). The LMW PAHs have high 
toxicity, volatility and solubility while those with HMW have low volatility, low solubility and are 
carcinogenic. When exposed to mammals, cytochrome p450 as well as other mammalian 
monooxygenases can convert PAHs to highly reactive epoxides that are capable of binding DNA 
with the potential to cause mutations (Nesnow, 2000). When exposed to the environment, PAHs 
undergo several fates that include photooxidation, chemical oxidation, hydrolysis, 
bioaccumulation, biodegradation, volatilization, and adsorption (DiBlasi, 2008). LMW PAHs are 
lost through volatization, processing by organisms (bacteria, fungus, plants), or oxidation while 
HMW PAHs adhere to soil particulates due to their hydrophobic nature. Adsorption of HMW 
PAHs leads to low bioavailability and increased recalcitrance that results in accumulation. For 
example, a 3-ring PAH will typically have a half-life in soil of 12 to 126 days while a 5-ring PAH 
can have a half-life of up to 1400 days (Shuttleworth, 1995). Almost 90% of PAH contamination 
is present in soil, but contamination in oceans does occur due to run off from contaminated rivers, 
seepage at deep sea vents, and oil spills at ocean surfaces (Wild, 1995). After the Deepwater 
Horizon oil spill in 2010, HMW PAHs represented 31% of the total PAH contamination while 
HMW PAHs represented only 8% of PAHs in crude oils (Boehm, 2011). Due to their recalcitrance, 






1.2 Polycyclic Aromatic Hydrocarbon Bioremediation 
a. Whole-Cell Bioremediation 
Excavation and filling of contaminated sites were the major route of remediation until the 
late 1990s (Kuppusamy, 2017). The development of alternative technologies resulted in physical 
remediation through washing and fixation, chemical remediation through extraction and 
dechlorination, thermal remediation through incineration and desorption, photooxidation, and 
bioremediation (Ghosal, 2016; Lamichhane, 2017). Bioremediation is preferred over chemical and 
physical remediation methods because it is a more efficient and environmentally-friendly option 
(Lamichhane, 2017). Owing to these benefits, research on microbes capable of degrading PAHs 
for the end-purpose of bioremediation has increased (Lamichhane, 2017). 
 
Through 3.5 billion years of evolution, microbes have acquired the genetic and functional 
diversity to adapt to almost any environment, even those unsuitable for most other organisms 
(Sogin, 2006). Microbes make up 60% of Earth’s biomass and are found in the most extreme 
environments (Nikolaivits, 2017). It is fitting that the task of not only surviving but of interacting 
and altering environments deemed toxic to most organisms would fall to microbes. Upon exposure 
of an environment to a foreign, toxic compound, the distribution of microbes shifts to become 
dominated by those with the ability to degrade or accumulate the toxin (Vila, 2010). As the toxin 
level decreases, the composition of the microbial community shifts back towards its natural 
balance (Vila, 2010). While microbes will naturally adapt to and alter a contaminated environment, 
this process is usually slow and allows for the accumulation of toxic intermediates that other, less-
resilient organisms cannot tolerate. Bioremediation is a process that takes advantage of a microbe’s 
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natural ability to restore an environment to pre-contaminated conditions by either supplying 
necessary nutrients that are limited in the environment (biostimulation) or by introducing 
exogenous microorganisms already optimized for degradation of the specific contaminant 
(bioaugmentation) (Mohan, 2006). Bioremediation may be performed at the site of contamination 
(in-situ), or the contaminated medium may be relocated for processing (ex-situ). In-situ processes 
are preferred because they are more environmentally- and economically-friendly, but they require 
more time for complete treatment (Perpetuo, 2011). Figure 1.1 gives examples of bioremediation 
techniques (Azubuike, 2016). When choosing a bioremediation technique, it is important to 
consider location, cost, environment type, pollutant characteristics, and the degree of pollution 
(Azubuike, 2016).  
 
Figure 1.1: Bioremediation techniques (Azubuike, 2016). 
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Biostimulation is used when the contaminated environment is inhabited by microorganisms 
capable of PAH degradation. Nutrients to stimulate growth, cofactors required for the degradation 
process, or surfactants to solubilize contaminants are added to increase the rate of remediation. 
Sun et al. showed that the addition of nitrogen and phosphate to soil from a contaminated coking 
plant in Beijing increased overall PAH degradation by 10% after 175 days when compared to 
degradation from the unadulterated soil (Sun, 2012). Bioaugmentation is used when PAH-
degrading bacteria are not present in these contaminated sites or when bioavailability is a limiting 
factor for remediation (Kuppusamy, 2017). The microbial species used for bioaugmentation is 
dependent on the microbe’s nutrient, oxygen, pH, and temperature requirements (Liu, 2017). 
Marine bacteria are commonly used for bioaugmentation because of their ability to thrive in a wide 
range of environmental conditions (low temperatures, high pressures, variable light intensities) 
(Nikolaivits, 2017). When bioavailability is a limiting factor, microbial strains able to produce 
biosurfactants capable of solubilizing and therefore increasing the bioavailability of PAHs may be 
used (Pedetta, 2013). When the biosurfactant-producing Pseudomonas aeruginosa organism was 
added to PAH-contaminated soil from a wood preservation factory in the U.S., the overall 
degradation of PAH increased 5 times that of the control soil-only sample after 14 days (Straube, 
1999). A mix of microbial species may be used to provide necessary nutrients or minimize the 
accumulation of toxic intermediates through crossfeeding (Bouchez, 1999). The highest 
degradation rate of PAHs recorded was achieved using a mixture of Pseudomonas, Cupriavidus, 
and Bacillus strains isolated from a contaminated manufactured gas plant site in Australia 
(Kuppusamy, 2016). This mixture degraded PAHs 44% faster than a sample of control soil. While 
bioaugmentation is an effective process, the remediation rate for HMW PAHs is typically still slow 
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compared to LMW PAHs. In a study by Kuppusamy (2016), complete degradation of both LMW 
and HMW PAHs was achieved using a consortium of microbes, but the degradation of the HMW 
PAHs benzo[a]pyrene and pyrene took 17 and 4 times longer respectively than that of the LMW 
PAH phenanthrene.  
 
b. Genetically Modified Microorganisms in Bioremediation  
Most contamination sites are polluted with multiple compounds which presents a 
challenge. While it is possible for microbes present at contaminated sites to evolve the ability to 
degrade the mixture, the evolution process is frequently slow and may not occur at all (Cases, 
2005). Bioaugmentation may not be feasible in some environments due to competition and lack of 
available resources (Cases, 2005). Identification of catabolic gene clusters and knowledge of their 
regulation as well as a sufficient understanding of the function, regulation, and stability of their 
associated enzymes allows for the construction of genetically modified microorganisms (GMMs) 
that can be used to enhance bioaugmentation (Wasilkowski, 2012). GMMs are used for optimized 
multi-toxin degradation without accumulation of toxic intermediates or energy loss due to increase 
in biomass (Kuppusamy, 2017).  GMMs used in bioremediation will have new catabolic pathways, 
optimized inherent catabolic activities, or biosensing abilities (Kuppusamy, 2017; Wasilkowski, 
2012; Timmis, 1999). GMMs used for bioaugmentation will typically have catabolic genes and 
gene clusters capable of complete degradation of a contaminant incorporated into the genome of 
an indigenous microbe under the control of a strong promoter (Cases, 2005). The use of GMMs 
for degradation of PAHs was first demonstrated by Gunsalus and Chakrabarty in 1981 with the 
development of the first patented living organisms (US Patent #425944), Pseudomonas aeruginosa 
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(NRRL B-5472) and Pseudomonas putida (NRRL B-5473). These two organisms were genetically 
modified by incorporation of genes for naphthalene, salicylate, octane, and camphor degradation 
and these organisms demonstrated the acquired ability to degrade those compounds.  
 
The use of an indigenous microbe eliminates the need for acclimation and increases the 
chances of survival. Genetic modifications can be used to optimize the natural degradation 
capabilities of an indigenous microbe through modification of transcription regulation of catabolic 
operons or through enhanced enzyme activation. Operon transcriptional regulation is typically 
achieved through a positive response from a regulatory protein after interaction with a contaminant 
or an intermediate of contaminant degradation (Ramos, 1997). Regulatory proteins can be mutated 
to give a stronger response, have a lower threshold of activation, or respond to an alternative 
stimulus. Coupling transcriptional regulation to an unnatural stimulus allows greater flexibility in 
the control of the catabolic response (Timmis, 1999; Cebolla, 1997). For example, placing the 
trichloroethylene (TCE) catabolic operon under the control of a starvation promoter allows the 
expression of the TCE catabolic genes in nutrient-limited environments like that of contaminated 
sites (Martin, 1995). Catabolic optimization through mutation of catabolic enzymes is achieved by 
altering enzyme stability, substrate specificity, or kinetic properties (Timmis, 1999). For example, 
in a study by Ge and Eltis, replacement of the substrate-determining subunit of benzoate 
dioxygenase from Acinetobacter calcoaceticus ADP1 with that from toluate dioxygenase of 
Pseudomonas putida mt-2 resulted in a broader substrate range for the Acinetobacter dioxygenase 
(Ge, 2003). Enhanced catalytic activity is typically accomplished through site-directed mutations 
of enzyme active sites but requires that the structure of the enzyme or analogous enzymes be 
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known. The use of enzyme modification in optimization of catabolic activity is limited by the small 
number of structures known for enzymes acting within catabolic pathways (Timmis, 1999).  
 
The use of biosensors is important in remediation to detect and monitor toxin levels 
throughout the process. A marker gene, such as lacZ, lux, or GFP, will be fused with the operon 
containing the desired gene to be monitored (Wasilkowski, 2012). When transcription of that 
operon is active, the marker gene will be expressed and the amount of transcription can be 
monitored. The use of a GMM as a biosensor was demonstrated initially using the first GMM 
approved for field application, Pseudomonas fluorescens HK44 (Sayler, 2000). This strain has a 
luminescent reporter gene linked to the naphthalene catabolic gene cluster and is used in the field 
to detect the presence of naphthalene as a reporter for enhanced PAH contamination (Sayler, 2000).  
 
c. Purified Enzymes in Bioremediation 
While the use of whole-cell microbes in bioremediation has had some success, there are 
limitations for this technique, including low viability of exogenous microbes due to incompatibility 
with the local environment, high toxicity and low bioavailability of contaminants, and the 
requirement for aeration, excess nutrients, or required cofactors for microbial growth (Eibes, 
2015). If exogenous microbes can survive the contaminated environment, they may alter the 
natural microbial balance by remaining long after contaminant levels have returned to normal. The 
use of purified wild-type or genetically modified enzymes for bioremediation has several 
advantages over whole-cell bioremediation including higher toxin specificity, little to no unwanted 
by-product formation, greater stability in the presence of high toxin concentrations, and greater 
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stability under various environmental conditions, such as wide pH, temperature, and redox 
potential ranges (Eibes, 2015). Also, enzymes will be degraded naturally and will not alter the 
environment by remaining in the soil over a long period of time. Directed evolution and enzyme 
engineering techniques may be used to broaden substrate specificity and enhance the kinetic 
properties of purified enzymes. The development of nanotechnologies for immobilization of 
enzymes can increase enzyme stability and prolong enzyme lifetime (Rayu, 2012). For example, 
Acevedo et al. showed that manganese peroxidase immobilized onto nanoclay had an increased 
stability at high temperatures and high pH and a longer storage life than free purified enzyme 
without a decrease in catalytic activity. This immobilized manganese peroxidase was capable of 
degrading 90% of anthracene present in a contaminated soil within 24 hours (Acevedo, 2010). As 
stability and catalytic efficiency increase, smaller scale production of enzymes will be required for 
bioremediation leading to reduced costs compared with whole-cell techniques. 
 
The number of enzymatic bioremediation experiments in the field is limited, but there are 
many examples of small-scale laboratory tests (Table 1.4) (Eibes, 2015). One of the few field 
experiments was performed in 2000 at an Air Base in Greenland for the degradation of waste fuel. 
A combination of free enzymes extracted from hydrocarbon-degrading cultures was used to 
enhance degradation by a bacterial consortium. The study resulted in complete degradation of 
LMW PAHs after 60 days and of HMW PAHs after 90 days (Vinson, 2000). In 2008, Wu et al. 
tested the ability of laccase isolated from Trametes sp. to degrade various PAHs in contaminated 
soil. Laccase showed moderate total PAH degradation after 14 days (32% degradation) but 
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completely degraded anthracene and benzo(a)pyrene after only 24 hours. Results like these are 
promising for the future of enzymatic bioremediation.  
 
Table 1.4: Reported enzyme technologies for bioremediation by 2015 (adapted from Eibes, 2015). 
TPH: total petroleum hydrocarbon; OP-A: phosphoesterase; HRP: horseradish peroxidase; MnP: 
manganese peroxidase; BGP: bitter gourd peroxidase; DDT: dichlorodiphenyltrichloroethane; 
DCP: dichlorophenol; PFC: perfluoroalkyl compounds. 
 
 
Technology Matrix Enzyme Pollutant Time Removal (%)
Free enzyme Soil TPH-degrading multienzyme complex Light hydrocarbons 30 days >95
Heavy hydrocarbons 90 days >95
Free enzyme Soil Landguard
TM
 OP-A Diazinon 1 h 77
Free enzyme Soil Laccase DDT 25 days 69
Free enzyme Soil Laccase DDT 15 days 51
Free enzyme Soil Laccase 15 PAHs 24 h 23, 86, 90
Free enzyme Soil Laccase 4-Methylphenol 2 days 91
DCP 14 days 88
Free enzyme Soil HRP (horseradish roots) 2,4-DCP 0.5 h 92
Free enzyme Soil HRP  Phenol 7 days 40-75
o-Cresol
DCP
Free enzyme Soil HRP (shepherd’s purse root) 2,4-DCP 3 h 95
Free enzyme Soil HRP 2,4-DCP 24 h 90
Free enzyme Soil Laccase Estradiol 264h 95
Free enzyme Soil HRP DCP 30 min 85
Immobilized Soil Laccase DCP 1 day 88
Immobilized Soil MnP Anthracene 24 h 86-90
Immobilized Soil Arthrobacter  sp. HB-5 Atrazine 144 h 90
Immobilized Soil Arthrobacter  sp. DNS10 Atrazine 21 days 90
Immobilized Soil Laccase Naphthalne 14 days 82
Phenanthrene
Slurry bioreactor Soil slurry Laccase PFC 15 days 72-91








Single phase bioreactor Acetone:water MnP Anthracene 3 days 28
Single phase bioreactor Acetone:water MnP Anthracene 7 h >95
Dibenzothiophene 24 h 95
Pyrene 24 h 61
Single phase bioreactor Acetone:water MnP Anthracene 11.5 h 90
Single phase bioreactor Acetone:DMF:water BGP Anthracene 7 h 99
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1.3 Mycobacteria and PAH Bioremediation 
a. Mycobacteria Characteristics 
Mycobacteria are aerobic, rod-shaped bacteria belonging to the Gram-positive 
Actinobacteria group that are found in diverse environments (Primm, 2004). Mycobacteria have 
been extensively studied for their ability to degrade a wide range of PAHs. Studies using HMW 
PAHs as the sole carbon and energy sources typically result in the isolation of Mycobacterium spp 
(Kim, 2010). Although Mycobacteria are slow growers they survive and even outcompete other 
fast-growing bacteria when PAHs are present in soil (Kim, 2010). After being the first isolated 
bacteria capable of degrading pyrene, much attention has been given to Mycobacterium 
vanbaalenii PYR-1. M. vanbaalenii PYR-1 was isolated in 1986 from a contaminated estuary near 
the Harbor Island oil tank at Redfish Bay, Texas (Heitkamp, 1988). Genomic, metabolomic, and 
proteomic data from M. vanbaalenii PYR-1 have been combined to elucidate degradation 
pathways for multiple PAHs, including naphthalene, phenanthrene, anthracene, fluoranthene, 
pyrene, benz[a]anthracene, and benzo[a]pyrene (Kim, 2010). Analysis of the M. vanbaalenii PYR-
1 genomic sequence annotates 194 genes as having roles in PAH catabolism (Kim, 2010). Most 
PAH catabolic genes are limited to two catabolic regions within the genome, region A at 494-643 
kb and region B at 4,711-4,741 kb, with others spread throughout the M. vanbaalenii PYR-1 
genome (Figure 1.2). Region A is specialized for HMW PAH degradation and contains all the 
genes necessary for HMW PAH catabolism. These genes are not organized into operons, as is 
typical for catabolic microbes. Instead, genes involved in a catabolic pathway are scattered among 
several gene clusters. For example, the genes responsible for the first three steps in pyrene 
degradation are found across 70 kb of DNA and 3 different gene clusters within region A and the 
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27 genes needed for complete pyrene degradation are found within 4 gene clusters. Analysis of the 
M. vanbaalenii PYR-1 genome shows redundancy in genes encoding enzymes for every step in 
PAH catabolism. For the first three steps in PAH catabolism there are 21 ring hydroxylating 
oxygenases (RHOs) (step 1), 50 cytochrome P450s (CYPs) (step 1), 5 dihydrodiol dehydrogenases 
(step 2), and 10 ring-cleaving dioxygenases (step 3). Many of these gene copies are found within 
the catabolic regions. The unstructured locations and redundancy of catabolic genes are likely 
caused by the presence of mobile genetic elements found throughout the catabolic regions. Due to 
the complex arrangement and duplication of genes, a sophisticated regulatory system is required 
to coordinate an appropriate response in the presence of a contaminant or catabolic intermediate 
(Kim, 2009). For example, the ring hydroxylating oxygenases NidAB and NidA3B3 are both 
capable of processing pyrene and fluoranthene in vivo but proteomic studies show that NidAB is 
upregulated only in the presence of pyrene while NidA3B3 is upregulated only in the presence of 
fluoranthene (Kim, 2006). Some genes have been identified that may be responsible for catabolic 
regulation, but their functions have not been confirmed (Kweon, 2010). The presence of multiple 


















Figure 1.2: PAH catabolic regions from Mycobacterium vanbaalenii PYR-1. Arrows indicate the  
direction of transcription and numbers above the arrows correspond to ORFs. Bold numbers 
signify genes expressed in the presence of pyrene and fluoranthene. Arrows are colored as follows: 
red: PAH catabolism, pink: transcriptional regulation, yellow: DNA mobilization, green: 
membrane transport system, blue: function outside of PAH degradation, white: no predicted 





b. Mycobacterium vanbaalenii PYR-1 Catabolism of PAHs  
When exposed to a PAH, Mycobacterium vanbaalenii PYR-1 follows a central catabolic 
pathway that converts the PAH to intermediates of the tricarboxylic acid (TCA) cycle or a 
peripheral pathway that results in a dead-end product (Kweon, 2011). The general pathway for the 
degradation of PAH by M. vanbaalenii PYR-1 with the most support by experimental evidence is 
shown in Figure 1.3 (Kim, 2008). Catabolism using the central pathway begins with activation by 
the addition of one oxygen molecule by cytochrome P450 (CYP) followed by hydrolysis of the 
resulting epoxide or the addition of two oxygen molecules by ring hydroxylating oxygenases 
(RHOs). Dehydrogenation of the resulting dihydrodiols forms dihydroxylated, rearomatized 
intermediates that are cleaved by ring-cleaving dioxygenases. The products are then processed by 
hydratase-aldolases. For PAHs with 3 or more rings the cycle is repeated until a single ring 
remains. The single-ring product is then processed to intermediates of the TCA cycle, ultimately 




















Figure 1.3: General PAH catabolism by Mycobacterium vanbaalenii PYR-1. Roman numerals 
represent the enzymatic steps. The number of enzymes associated with each step found within the 




Additional catabolic pathways in M. vanbaalenii PYR-1 are necessary when PAH levels 
are higher than can be processed through the central pathway or when central pathway 
intermediates spontaneously form toxic compounds (Kweon, 2010). Catechol compounds created 
after the first two steps may spontaneously oxidize to form genotoxic quinone species. Quinone 
reductases, such as catalase peroxidase and superoxide dismutase, can reduce these reactive 
species back to catechols that can feed back into the central degradative pathway (Kweon, 2010). 
The highly reactive hydroxylated intermediates may also be methylated by O-methyltransferases 
to less reactive methoxy compounds through a peripheral detoxification pathway (Kim, 2008). 
Products of the peripheral detoxification pathways cannot be used by the microbe for energy 
production, so they are typically eliminated through transport out of the cell (Kweon, 2010). The 
pyrene catabolic pathway provides examples of both the central and detoxification pathways 
(Scheme 1.1). The central pathway begins with hydroxylation at C-4 and C-5 (1) and follows a 
catabolic route like that described above. The detoxification pathway begins with hydroxylation 
and dehydrogenation at positions C-1 and C-2 (2 and 3) followed by methylation of both oxygens 









Scheme 1.1: Degradation pathway for pyrene by M. vanbaalenii PYR-1 (Adapted from ref. Kim, 
2007) 
 
c. Mycobacteria Physiological Responses  
In addition to having the genetic capability to degrade various hydrocarbons, 
Mycobacterium spp. have other characteristics and physiological responses to PAHs that enhance 
their ability to degrade these PAHs. The low oxygen concentration at contamination sites is 
typically a limiting factor for PAH degradation because many enzymes involved in PAH 
degradation require oxygen as a substrate (Kim, 2010). Fritzsche showed that an isolated 
Mycobacterium sp. was capable of degrading pyrene while limiting cell growth in oxygen 
concentrations that are typically too low for PAH degradation by other aerobic bacteria (Fritzsche, 
1994). HMW PAHs can be quite large and passive diffusion through the cell membrane may be 
difficult. M. vanbaalenii PYR-1 has 23 ORFs within regions A and B that are involved in 
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membrane transport and function to transport PAHs and necessary nutrients into the cell (Kim, 
2008). HMW PAHs are highly recalcitrant because of their hydrophobicity and low bioavailability. 
Mycobacteria have cell walls with thick, hydrophobic cell envelopes rich in mycolic acids. When 
exposed to PAH contaminants, Mycobacteria can modify their cellular envelopes by increased 
production of mycolic acid with longer fatty chains to better adhere to and increase the 
bioavailability of hydrophobic PAHs. For example, when a Mycobacterium sp. is grown with solid 
anthracene as the sole carbon source it alters the composition of its cell surface which allows it to 
produce a biofilm on anthracene and increase anthracene bioavailability (Wick, 2002). Bogan et 
al. showed that after growth on soil supplemented with phenanthrene, M. vanbaalenii PYR-1 had 
a high membrane hydrophobicity (52%), significantly higher than that of LMW PAH-degrading 
bacteria (0-26%) (Table 1.5) (Bogan, 2003). These physiological adaptions to the presence of PAH 
contaminants and the local environment of contaminated soils make Mycobacteria well-suited to 
thrive within contaminated environments.   
 
Table 1.5: Measured hydrophobicity after growth in mineral salts medium (MSM), or MSM with 
added yeast extract, peptone, and starch (YPS) supplemented with phenanthrene (Bogan, 2003).    
 
 
Isolate Medium Culture age (days) Hydrophobicity (%)
Acidovorax temperans  GTI-19 MSM/phenanthrene 1 3
Burkholderia  sp. GTI-3 MSM/phenanthrene 6 15
Pseudomonas viridiflava  GTI-5 MSM/phenanthrene 6 4
Sphingomonas  SP. GTI-7 MSM/phenanthrene 2 15
Sphingomonas  SP. GTI-8 MSM/phenanthrene 6 26
Sphingomonas  SP. GTI-10 MSM/phenanthrene 6 0
Sphingomonas SP. GTI-11 MSM/phenanthrene 6 18
Sphingomonas subarctica  GTI-12 MSM/phenanthrene 2 0
Mycobacterium austroafricanum GTI-23 YPS/phenanthrene 6 48
Mycobacterium austroafricanum  ATCC 33464 YPS  6 41
Mycobacterium  sp. PYR-1 YPS/phenanthrene 6 52
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d. M. vanbaalenii PYR-1 in Bioremediation of PAHs 
M. vanbaalenii PYR-1 is specialized for the degradation of HMW PAHs through its 
physiological and genetic adaptations and is an ideal candidate for use in bioremediation efforts. 
In 2003, M. vanbaalenii PYR-1 was used in a two-phase partitioning bioreactor to degrade 
phenanthrene, pyrene, naphthalene, and anthracene contaminants. M. vanbaalenii PYR-1 
completely degraded phenanthrene and pyrene within 4 days (168 mg/L/day and 38 mg/L/day) 
and degraded 75% of naphthalene and 95% of anthracene after 10 days (14.5mg/L/day and 
40mg/L/day) (MacLeod, 2003). Although these results are promising, documentation of 
applications of M. vanbaalenii PYR-1 for bioremediation since 2003 has not been reported.  
 
M. vanbaalenii PYR-1 HMW PAH degradation pathways are overlapping and complex. Many 
enzymes within these pathways have relaxed substrate specificities and may be functional in 
multiple pathways. For M. vanbaalenii PYR-1 to be used efficiently in bioremediation applications 
it is important that the expression of the enzymes assigned to the various transformations in the 
proposed pathways be confirmed and that enzymatic mechanisms and regulation of various 
pathways be well understood (Kim, 2008; Kweon, 2010). Proteomic and genomic analysis has 
elucidated genes that are involved in specific catabolic pathways under limited conditions, but 
systems biology experiments under various conditions will give insights into the regulation of gene 
expression and enzyme functions (Kweon, 2010). The roles of many of these genes are assigned 
based on homology with known enzymes. Biochemical evidence for enzyme functions and 
identification of intermediates is needed to confirm the annotated pathways (Kweon, 2010). The 
work presented in this dissertation provides some of the much needed biochemical evidence.  
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Chapter 2: Investigation of the Ring-Cleaving Dioxygenase and Hydratase-




Naphthalene is one of the most common pollutants found in petroleum-contaminated sites. 
After inhalation of naphthalene, cytochrome P450 enzymes process naphthalene into compounds 
that display pulmonary toxicity in mice and olfactory and respiratory toxicity in rats, but the 
evidence for naphthalene toxicity in humans is controversial (Hu, 2014; Abdo, 2001; Bailey, 2016; 
Li, 2017). Bacterial degradation is the predominant means for lowering naphthalene concentration 
in the environment. The series of reactions used to process one aromatic ring of the naphthalene 
system represents a major strategy that is repeated in other PAH catabolic pathways. Hence, 
elucidation of the bacterial naphthalene catabolic pathway is critical for elucidation of other, more 
complex PAH catabolic pathways. While much work has been done to elucidate the naphthalene 
catabolic pathways for various bacteria, little work has been done to elucidate the naphthalene 
catabolic pathway in Mycobacterium vanbaalenii PYR-1 (Seo, 2009; Kelley, 1990). Kelley et al. 
isolated metabolites after introducing a culture of M. vanbaalenii PYR-1 to naphthalene and 









Scheme 2.1: Metabolites isolated after growth of M. vanbaalenii PYR-1 in the presence of 
naphthalene. Compounds in brackets were not isolated (adapted from Kelley, 1990). 
 
The generally accepted naphthalene catabolic route that agrees with the isolated 
metabolites is shown in Scheme 2.2. This pathway was first characterized for plasmid NAH7 in 
Pseudomonas putida G7 (Schell, 1983). The pathway begins with oxidation of naphthalene (5) at 
C-1 and C-2 to produce 6, followed by dehydrogenation to aromatize the ring (7). The ring is 
opened via a dioxygenase-catalyzed cleavage at the meta position (indicated on 7) and the product 
non-enzymatically cyclizes to 8. Typically, a glutathione-dependent isomerase catalyzes the cis to 
trans isomerization of 8 to 9 before a hydratase-aldolase cleaves 9 to salicylaldehyde (10) and 
pyruvate. The aldehyde is oxidized to salicylic acid (11) and is further processed through the 




Scheme 2.2: Proposed naphthalene catabolic pathway by M. vanbaalenii PYR-1. 
The catabolism of some HMW-PAHs produces an intermediate, 1-hydroxy-2-naphthoate 
(12), that is structurally similar to 1,2-dihydroxynaphthalene (7). For example, the upper catabolic 
pathway for pyrene ends in the production of 12 (Kim, 2007) (Scheme 2.3). The lower catabolic 
pathway begins with cleavage of 12 at the ortho position to produce 13 that is processed to 2-
carboxybenzaldehyde. The pathway ends with the production of phthalate that can ultimately feed 
into the TCA cycle. Proteomic studies performed after growth of M. vanbaalenii PYR-1 in the 
presence of pyrene show that iron-dependent dioxygenases (designated PhdI and PhdF) and 
hydratase-aldolases (designated PhdJ and PhdG) are upregulated (Kim, 2007; Kweon, 2007). PhdF 
is annotated as a type I extradiol dioxygenase and is thought to catalyze the ring cleavage of 19 
and 36. PhdG catalyzes hydration of the ring-opened product of 24 followed by a retro-aldol fission 
to produce 26 in the upper catabolic pathway (Scheme 2.3). PhdI is annotated as an intradiol 
dioxygenase and is thought to be responsible for ortho-ring cleavage of 12 and PhdJ is responsible 
for hydration of 13 and subsequent retro-aldol fission in the lower catabolic pathway.  
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Scheme 2.3: The catabolism of pyrene by M. vanbaalenii PYR-1 (adapted from Kim, 2007).  
Only the enzymes responsible for the ring-hydroxylating and dehydrogenation steps in the 
naphthalene catabolic pathway in M. vanbaalenii PYR-1 have been experimentally characterized. 
The gene products of several ring-hydroxylating oxygenase genes within the PAH catabolic 
regions (Figure 1.2) have been shown to hydroxylate naphthalene (to produce 6 in Scheme 2.2), 
although at slower rates than HMW PAHs (Kim, 2006; Kweon, 2014). Although there are several 
ring-cleaving dioxygenase and hydratase-aldolase genes within the catabolic regions of M. 
vanbaalenii PYR-1, no enzymes have been identified and assigned as those that catalyze ring-
cleavage or hydratase-aldolase reactions within the naphthalene catabolic pathway. There is no 
gene within the PAH catabolic regions that has significant sequence similarity with an isomerase 
known to be active within naphthalene catabolic pathways (NahD of the NAH7 plasmid in 
Pseudomonas putida G7), and no annotated isomerase is upregulated in M. vanbaalenii PYR-1 in 
the presence of PAHs (Thompson, 2007; Kweon, 2007; Kim, 2007). It is predicted that the non-
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enzymatic cis to trans isomerization of 8 to 9 is sufficient and no isomerase is required (Scheme 
2.2).  
Based on the structural similarities of 12 with 7 (CO2
- vs OH) and 13 with 9 (CO2
- vs OH), 
it is possible that the enzymes that cleave 12 and 13 can also cleave 7 and 9 (Scheme 2.4). PhdI 
has a modest sequence similarity (46%) with a cupin superfamily type III extradiol dioxygenase 
(PhdI from Nocardioides sp KP7) known to cleave 12 in the ortho position (between substituents) 
(Iwabuchi, 1998). PhdI from Nocardioides sp KP7 is unique in that it requires ferrous iron to 
cleave its substrate in the ortho position whereas other ortho ring-cleaving dioxygenases require 
ferric iron (Iwabuchi, 1998). It is possible that PhdI from M. vanbaalenii PYR-1 can catalyze 
cleavage of 12 at the ortho position and 7 at the meta position (adjacent to substituents) (Bugg, 
2003; Iwabuchi, 1998). It is also possible that PhdI cleaves 7 in the ortho position and/or 12 in the 
meta position (Scheme 2.4). If PhdI cleaves 7 in the ortho position, a hydratase-aldolase would 
degrade the product 15 to 2-carboxybenzaldehyde (16) that is oxidized and processed through the 
phthalate catabolic pathway (Keum, 2006; Seo, 2006; Seo, 2007). If PhdI cleaves 12 at the meta 
position, a hydratase-aldolase would degrade the product 14 to salicylaldehyde that is further 
processed through the catechol catabolic pathway that feeds into the TCA cycle (Roy, 2014).  
Although PhdF likely acts in the upper catabolic pathway for pyrene, PhdF is the gene 
product in M. vanbaalenii PYR-1 with the highest sequence similarity (35%) to a type I extradiol 
dioxygenase (NahC of the NAH7 plasmid Pseudomonas putida G7) known to ring-cleave 7 at the 
meta position and may be responsible for catalyzing this reaction. PhdJ is the gene product in M. 
vanbaalenii PYR-1 with the highest sequence similarity (45% and 56%, respectively) to hydratase-
aldolases known to catalyze the hydration of 9 and subsequent retro-aldol cleavage (NahE of the 
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NAH7 plasmid in Pseudomonas putida G7) and the hydration of 13 and subsequent retro-aldol 
cleavage (PhdJ of Nocardioides sp. KP7) and is likely responsible for catalyzing both reactions. 
PhdG also has high sequence similarity to these hydratase-aldolases (36% and 34%, respectively) 
and may also be able to catalyze these reactions.  
Scheme 2.4: Possible ring-cleavage reactions of 1,2-dihydroxynaphthalene (7) and 1-hydroxy-2-
naphthoate (12) and subsequent hydratase-aldolase reactions.  
 
One goal of this work is to determine which oxygenase, PhdI or PhdF, is responsible for the 
cleavage of 7 and/or 12 and at what position the cleavage occurs (Scheme 2.4). We also want to 
determine if an enzyme is required to catalyze the isomerization of the cleavage products and 
which hydratase-aldolase, PhdJ or PhdG, catalyzes cleavage of these products (9 or 15 and 13 or 
14). Products of each reaction were isolated and identified and kinetic analysis was performed.    
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2.2 Experimental Procedures 
Materials 
Chemicals, biochemicals, buffers, and solvents were purchased from Sigma-Aldrich 
Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), Fluka Chemical Corp. 
(Milwaukee, WI), or EMD Millipore, Inc. (Billerica, MA). 1,2-Dihydroxynaphthalene, 1-hydroxy-
2-naphthoic acid, salicylaldehyde, 2-carboxybenzaldehyde, and 2-hydroxybenzaldehyde were 
purchased from Sigma-Aldrich Chemical Co. The Gibson Assembly Cloning Kit was purchased 
from New England Biolabs, Inc (Ipswich, MA). The DEAE-Sepharose resin, the HiLoad 16/60 
Superdex resin, and the Sephadex G-25 resin were obtained from GE Healthcare (Piscataway, NJ). 
The HisPur Ni-NTA resin was purchased from Sigma-Aldrich Chemical Co. The EconoColumn 
chromatography columns were obtained from BioRad (Hercules, CA). The Amicon stirred cell 
concentrators and ultrafiltration membranes (10000 Da cutoff) were purchased from EMD 
Millipore Inc.  
 
Bacterial Strains, Plasmids and Enzymes 
The pET vectors were obtained from Novagen (Madison, WI). Escherichia coli strain 
C41(DE3) and TEV protease were obtained from Sigma-Aldrich Chemical Co. E. coli 
ArcticExpress cells were obtained from Agilent Technologies (Santa Clara, CA). Isolated genomic 
DNA from Mycobacterium vanbaalenii PYR-1 was a gift from the laboratory of Dr. Carl Cerniglia 
(National Center for Toxicology Research, Food and Drug Administration, Jefferson, AR). PhdJ 




Oligonucleotide primers were synthesized by Sigma-Aldrich Co. The PCR amplification 
of DNA was conducted in a GeneAmp 2700 thermocycler (Applied Biosystems, Carlsbad, CA). 
The GenElute gel extraction kit was purchased from Sigma-Aldrich Co. Enzymes and reagents 
used for molecular techniques were purchased from New England Biolabs, Inc. DNA sequencing 
was performed in the DNA Core Facility in the Institute for Cellular and Molecular Biology 
(ICMB) at the University of Texas at Austin. The QIAprep spin miniprep kit was purchased from 
Qiagen (Hilden, Germany). Sonication was performed using a W385 sonicator of Heat systems-
ultrasonics, Inc. (Farmingdale, NY). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) was carried out on a Bio-Rad Mini-Protean II gel electrophoresis apparatus. Protein 
concentrations were determined using the Bradford method (Bradford, 1976). Electrospray 
ionization mass spectrometry (ESI-MS) was carried out on an LCQ electrospray ion-trap mass 
spectrometer (Thermo, San Jose, CA) housed in the ICMB Protein and Metabolite Analysis 
Facility at the University of Texas. Steady-state kinetic assays were performed on an Agilent 8453 
diode-array spectrophotometer. Nonlinear regression data analysis was performed using the 
program Grafit (Erithacus Software Ltd., Staines, U.K.). Nuclear magnetic resonance (NMR) 
spectra were recorded on a Varian UNITY+ 300 MHz (Palo Alto, CA). NMR signals were 





Cloning of M. vanbaalenii PYR-1 genes 0468 (PhdI), 0469 (PhdJ), 0470 (PhdF) and 0472 
(PhdG) 
For PhdI and PhdF, amplification of the desired genes was achieved through two rounds 
of PCR. The first round used overhang PCR primers that annealed within 100 bp around the desired 
gene. The second round isolated the desired gene flanked with appropriate restriction sites. For 
PhdJ and PhdG, amplification of the desired genes was achieved through a single round of PCR. 
Primers used for PCR are shown in Table 2.1. The 100 µl amplification reaction contained the M. 
vanbaaleni PYR-1 genomic DNA as a template (15 ng), dNTPs (0.4 mM), MgCl (2 mM), primers 
(0.4 µM), 1x buffer, and Vent Polymerase (1 unit). The PCR amplification protocol consisted of a 
5 min denaturation step at 94°C followed by 35 cycles of 94°C for 1 min, 55°C for 1 min, and 
72°C for 3 min and ended with a 10 min elongation step at 72°C.  The PCR reaction product size 
was confirmed on a 1% agarose gel and isolated using the GenElute gel extraction kit and elution 
into 60 µL of water. The PCR products were inserted into pET24 or pET32 between appropriate 
restriction sites (Table 2.1) using digestion and ligation procedures reported elsewhere (Deininger, 
1990). For PhdG, a sequence encoding a C-terminal His-tag and TEV cleavage site was inserted 
using a Gibson Assembly cloning kit following the manufacturer's protocol. An aliquot of the 
individual ligation mixture (30 µL) of PhdJ and PhdG was transformed into E. coli Arctic Express 
cells using a calcium heat shock method (Deininger, 1990). An aliquot of the individual ligation 
mixture (30 µL) of PhdI and PhdF was transformed into E. coli C41(DE3) using a calcium heat 
shock method. Transformed cells were grown on agar plates containing the appropriate antibiotic 
(100 µg/mL ampicillin for pET32 and 50 µg/mL kanamycin for pET24) at 37 °C overnight. A 
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single colony was used for the generation of additional plasmid for sequencing and protein 
expression.  
Table 2.1: Primers used for cloning of PhdI, PhdF, PhdJ, and PhdG genes from M. vanbaalenii 
PYR-1. 
 
Expression of Enzymes 
PhdI and PhdF 
LB media cultures (25 mL) containing ampicillin (100 µg/mL) were inoculated using a 
single colony and grown overnight at 37 °C. LB media cultures (1.6 L) were inoculated using an 
appropriate amount of the overnight culture to make OD600 = 0.05 A.U and grown at 37°C for 2.5 
h. Protein expression was induced overnight (18 h) at 21 °C using a final isopropyl-β-D-
thiogalactoside concentration of 0.1 mM. Cells were harvested by centrifugation (10,000 × g) with 
yields ranging from 3-5 g and stored at −80 °C. 
 
Purification of Enzymes 
PhdI and PhdF 
Cells were suspended to a final concentration of 10 mg/mL in Buffer A (20 mM HEPES, 
300 mM NaCl, pH 7) with 15 mM imidazole. Cells were disrupted by sonication and the resulting 
solution was centrifuged for 30 min at 17,700 × g and 4 °C. The supernatant was loaded onto a Ni-
NTA column (1 × 10 cm, ~6 mL resin) pre-equilibrated with Buffer A + 15 mM imidazole. The 
column was washed with Buffer A + 70 mM imidazole and the desired protein was eluted with 
Gene Overhang Fwd Primer Overhang Reverse Primer Fwd Primer Reverse Primer Vector
PhdI CCCAAGAGGTCAGCTCAGTG GGAGGGCGTAGGGATAATGC TAGCCAGGATCCTCCACCGCC GAATCGGAATTCTCAGCGGGC BamHI EcoRI pET32
PhdJ - - CGAGAGAGCATATGGTGCACGT TCCTCAGGATCCGTGGTTCGAGAC NdeI BamHI pET24a
PhdG - - CACGGCTCGGATCCACAACACG CCGGCGTGAGCTCCTATGACGAGG BamHI SacI pET24a
Restriction Enzymes
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Buffer A + 90 mM imidazole. Protein purity was confirmed by the observation of a single band 
on an SDS-PAGE gel stained with Coomassie blue. The eluant was concentrated to ~1 mg/mL and 
exchanged into 20 mM HEPES, 300 mM NaCl, 5% glycerol, pH7 (Buffer B) using an Amicon 
stirred cell equipped with an ultrafiltration membrane (10,000 Da cutoff). 
 
Activation of PhdF 
To activate PhdF, ascorbate (4 mM final), Iron(II) chloride (2 mM final) and acetone (5% 
final) were added to aliquots (~500 ul) of protein (1 mg/mL final concentration) purified as 
described above and the resulting mixture was incubated on ice for 30 min. The sample was 
centrifuged for 5 min at 20,800 × g and exchanged into Buffer B using a PD-10 column. Activity 
decreases within 8 h of activation so protein is activated and assayed on the same day.  
 
Product Identification  
Reaction of PhdI with 1,2-Dihydroxynaphthalene (7) 
PhdI was purified as described above. Aliquots of PhdI (1 – 10 µL, 6 – 60 nM final) and 
1,2-dihydroxynaphthalene in ethanol (1 µM – 1 mM final) were added to Buffer A (1 mL) and the 
reactions monitored using UV spectroscopy. No change in absorbance other than that caused by 
non-enzymatic oxidation was observed.  
 
Reaction of PhdI with 1-Hydroxy-2-Naphthoate (12) 
PhdI-expressing E. coli cells (1.2 g), prepared as described above, were suspended in 40 
mL of 20 mM HEPES at pH 7.0, lysed by sonication and the resulting solution was centrifuged 
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for 30 min at 17,700 × g and 4 °C. The supernatant was diluted to 150 mL using 20 mM HEPES 
at pH 7.0 and 1-hydroxy-2-naphthoate (25 mg in 1.5 mL ethanol) was added dropwise to the 
supernatant, which was stirring on ice. Aliquots (1 mL) of the solution were removed every 5 min, 
centrifuged at 20,800 × g for 2 min, and the clarified supernatant was monitored by UV 
spectroscopy until the reaction was complete (30 min) as determined by no further increase in 
absorbance at 294 nm. The reaction was centrifuged at 10,000 × g and 4 °C for 20 min. The pH of 
the clarified supernatant was adjusted to 8.0 using drops of 10 M potassium hydroxide. Proteins 
were removed using an Amicon stirred cell concentrator equipped with an ultrafiltration membrane 
(10,000 Da cutoff). The protein-free flow-through was concentrated in vacuo to 1.5 mL and loaded 
onto a Sephadex G-25 column. The column was washed with water and the eluate monitored using 
UV spectroscopy (294 nm). The product-containing fractions (~10 mL) were combined and dried 
in vacuo. The product was resuspended in ~0.6 mL of CDCl3, placed in an NMR tube, and a 
1H 
NMR spectrum was obtained. The 1H NMR spectrum matched that of pure trans-o-
carboxybenzylidenepyruvate (13, Scheme 2.4). 
 
Reaction of PhdF with 1,2-Dihydroxynaphthalene (7) and 1-Hydroxy-2-Naphthoate (12) 
PhdF was purified and activated as described above. Aliquots of PhdF (20 nM – 1 µM 
final) and 1,2-dihydroxynaphthalene in ethanol (1 µM – 1mM final) or 1-hydroxy-2-naphthoate in 
ethanol (2 – 80 µM final) were added to 1 mL of 20 mM HEPES at pH 7.0 and the reaction 
monitored using UV spectroscopy. No change in absorbance other than that caused by non-
enzymatic oxidation was observed for either compound.  
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Reactions of PhdJ and PhdG with trans-o-Hydroxybenzylidenepyruvate (HBP, 9) 
Aliquots of PhdJ (210 nM final) or PhdG (230 nM final) prepared as described above were 
added to 1 mL of 20 mM HEPES at pH 7.0. An aliquot of HBP in ethanol (30 µM final) was added 
to initiate the reaction. The reaction was monitored by following an increase in absorbance at 255 
nm until completion as determined by no increase in absorbance. The resulting spectrum of the 
products was compared to the spectrum of an aliquot of pyruvate (dissolved in ethanol) in 1 mL 
of 20 mM HEPES at pH 7.0 (20 µM final) and an aliquot of salicylaldehyde (dissolved in ethanol) 
in 1 mL of 20 mM HEPES at pH 7.0 (40 µM final).  
 
Reactions of PhdJ and PhdG with trans-o-Carboxybenzylidenepyruvate (CBP, 13) 
Aliquots of PhdJ (20 nM final) or PhdG (320 nM final) prepared as described above were 
added to 1 mL of 20 mM HEPES at pH 7.0. An aliquot of CBP in ethanol (30 µM final) was added 
to initiate the reaction. The reaction was monitored by following the decrease in absorbance at 300 
nm until completion as determined by no further decrease in absorbance. The resulting spectrum 
of the products was compared to the spectrum of an aliquot of pyruvate (dissolved in ethanol) in 1 
mL of 20 mM HEPES at pH 7.0 (20 µM final) and an aliquot of 2-carboxybenzaldehyde (dissolved 







Steady-State Kinetic Analysis  
PhdI with 1-Hydroxy-2-Naphthoate (12) 
An aliquot of pure PhdI (2 µL) prepared as described above was added to 1 mL of 20 mM 
HEPES at pH 7.0 to give a final concentration of 19 nM. Assays were initiated by the addition of 
aliquots of a stock solution of 1-hydroxy-2-naphthoate in ethanol (34 mM). The final substrate 
concentration ranged from 3 – 270 µM. The reaction was monitored by following an increase in 
absorbance at 300 nm (ε = 8637 M−1 cm−1). Initial rates were determined from the first 30 s of the 
reaction, plotted versus substrate concentration, and fit to the Michaelis-Menten equation to 
calculate the steady-state parameters kcat and KM using Grafit (Johnson, 2011). 
 
PhdJ and PhdG with trans-o-Hydroxybenzylidenepyruvate (9) and trans-o-
Carboxybenzylidenepyruvate (13) 
Aliquots of PhdJ or PhdG were added to 20 mM HEPES at pH 7.0 to final enzyme 
concentrations of 21 nM and 210 nM for PhdJ and 320 nM and 230 nM for PhdG. The assays were 
initiated by the addition of aliquots of a stock solution of HBP (19 mM in ethanol) or CBP (3 mM 
and 5.2 mM in ethanol). Final concentrations are summarized in Table 2.2. The reactions with 
HBP were monitored by following an increase in absorbance at 255 nm (ε = 7,896 M−1 cm−1). The 
reactions with CBP were monitored by following a decrease in absorbance at 300 nm (ε = 8,637 
M−1 cm−1). Initial rates were determined from the first 60 s of the reaction, plotted versus substrate 
concentration, and fit to the substrate inhibition or Michaelis-Menten equation to calculate the 
steady-state parameters kcat, KM, and Ki using Grafit (Johnson, 2011; Haldane, 1930).  
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Table 2.2: Enzyme and substrate concentrations for hydratase-aldolase kinetic assays.  
 
Coupled Assays using PhdI and PhdJ or PhdG 
A coupled assay was used to follow the reactions of PhdJ and PhdG with the ring-opened 
product generated from 1-hydroxy-2-naphthoate using PhdI. The reactions were initiated by 
adding 100 µL of PhdI supernatant prepared as described above and various concentrations of 1-
hydroxy-2-naphthoate in ethanol (0.6 to 40 µM for PhdJ and 4 to 114 µM for PhdG) to 1 ml of 20 
mM HEPES at pH 7.0. The reactions were monitored by following the increase in absorbance of 
the product at 300 nm until completion as determined by no further change in absorbance (< 5 
min). Upon completion, aliquots of PhdJ (75 nM final) or PhdG (240 nM final) were added and 
the decrease in absorbance at 300 nm (ε = 8,637 M−1 cm−1) was followed. Initial rates were 
determined from the first 60 s of the reaction, plotted versus substrate concentration, and fit to the 
substrate inhibition or Michaelis-Menten equation to calculate the steady-state parameters kcat, KM, 







Product Identification  
Reactions of PhdI with 1,2-Dihydroxynaphthalene (7) and 1-Hydroxy-2-Naphthoate (12) 
No reaction was observed when PhdI was incubated with 1,2-dihydroxynaphthalene. To 
determine the ring-opening position of 1-hydroxy-2-naphthoate (12) by PhdI, the two were mixed 
and the reaction was allowed to reach completion. The absorbance spectrum for the reaction is 
shown in Figure 2.1. The decrease at 250 nm corresponds to the decrease in concentration of 12 
and the increase at 301 nm corresponds to the increase in the concentration of the product. The 
product of the reaction was isolated and identified using 1H NMR spectroscopy. The product was 
determined to be CBP (13) and the proposed ortho-cleavage reaction shown in Scheme 2.3 was 
confirmed.  
 
Figure 2.1: Absorbance spectra following the reaction of PhdI and 1-hydroxy-2-naphthoate (12). 
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Reactions of PhdF with 1,2-Dihydroxynaphthalene (7) and 1-Hydroxy-2-Naphthoate (12) 
No reaction was observed when PhdF was incubated with 1,2-dihydroxynaphthalene (7) or 
with 1-hydroxy-2-naphthoate (12). 
 
Reactions of PhdJ and PhdG with trans-o-Hydroxybenzylidenepyruvate (9) and trans-o-
Carboxybenzylidenepyruvate (13) 
To identify the products of the reactions of PhdJ and PhdG with 9 and 13, the enzymes and 
substrates were mixed, and the reactions were allowed to reach completion. The absorbance 
spectra for the reactions of PhdG with 9 and PhdJ and 13 are shown in Figure 2.2. For the reaction 
using HBP, the decrease in absorbance at 293 nm corresponds to the decrease in concentration of 
HBP and the increase in absorbance at 255 nm corresponds to the increase in concentration of the 
product (10). For the reaction using CBP, the decrease in absorbance at 300 nm corresponds to a 
decrease in the concentration of CBP. The absorbance spectra for the reaction of PhdJ with HBP 
and PhdG with CBP match those shown. Absorbance spectra for pyruvate, salicylaldehyde and 2-
carboxybenzaldehyde, the proposed reaction products, were obtained and compared to the 
absorbance spectra for the actual reaction products (Figure 2.3). The product spectra matched the 








Figure 2.2: Absorbance spectra for the reaction of A) PhdG and HBP (9) and B) PhdJ and CBP 
(13). 
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Figure 2.3: Absorbance spectrum of (A) the product of the reaction of PhdG and HBP (solid line), 
pyruvate (dotted line), and salicylaldehyde (dashed line) and B) the product of the reaction of PhdJ 
and CBP (solid line), pyruvate (dotted line), and 2-carboxybenzaldehyde (dashed line).  
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Steady-State Kinetic Analysis  
PhdI with 1-Hydroxy-2-Naphthoate (12) 
Kinetic parameters were determined for the reaction of PhdI and 1-hydroxy-2-naphthoate 
(12). A graph of kobs vs 1-hydroxy-2-naphthoate concentration is given in Figure 2.4. The data are 
fit to the Michaelis-Menten equation (Johnson, 2011). The kinetic parameters are given in Table 




Figure 2.4: Plot of kobs vs 1-hydroxy-2-naphthoate concentration for the reaction with PhdI. Data 
are fit to the Michaelis-Menten equation (Johnson, 2011). 
 
 





PhdJ and PhdG with trans-o-Hydroxybenzylidenepyruvate (9) and trans-o-
Carboxybenzylidenepyruvate (13) 
The kinetic parameters were determined for the reactions of PhdJ and PhdG with HBP (9) 
and CBP (13). Plots of kobs vs substrate concentration for each reaction are given in Figure 2.5. 
Data for the reaction of PhdG with HBP displays substrate inhibition and is fit to the substrate 
inhibition equation (Haldane, 1930). All other reactions appear to obey classic Michaelis-Menten 
kinetics and the data are fit using the Michaelis-Menten equation (Johnson, 2011). The kinetic 
parameters are given in Table 2.4. The kcat/KM values for the reaction of PhdJ and PhdG with HBP 
are identical (1.8 x 104 M-1s-1). The kcat/KM value for the reaction of PhdJ with CBP is 14-fold 


























Figure 2.5: Plots of kobs vs substrate concentration for each hydratase-aldolase reaction. The data 
for the reaction of PhdG with HBP are fit to the substrate inhibition equation (Haldane, 1930). All 
other data are fit to the Michaelis-Menten equation (Johnson, 2011).  
 
 




Coupled Assays using PhdI and PhdJ or PhdG 
Coupled assays were used to determine whether PhdG and PhdJ could directly process the 
product of the reaction of PhdI and 1-hydroxy-2-naphthoate (12 to 13). The absorbance spectra of 
the substrate 1-hydroxy-2-naphthoate (12), the product of the reaction of PhdI and 1-hydroxy-2-
naphthoate (13), and the product after addition of PhdJ (16) are shown in Figure 2.6. The 
absorbance spectra for the reaction using PhdG matches that shown in Figure 2.6. Kinetic analysis 
was performed for these reactions and graphs of kobs vs substrate concentration are shown in Figure 
2.7. The data are fit to the Michaelis-Menten equation (Johnson, 2011). Kinetic parameters are 
given in Table 2.5. The kcat/KM value for the reaction with PhdJ is 2-fold higher than that with 
PhdG.  
Figure 2.6: Absorbance spectrum of 1-hydroxy-2-naphthoate (solid line), after the addition of PhdI 





Figure 2.7: Plots of kobs vs 1-hydroxy-2-naphthoate concentration for the coupled assay using PhdI 










Table 2.5: Kinetics parameters for the coupled assays with PhdI, 1-hydroxy-2-naphthoate, and 







PhdI, a dioxygenase encoded by a gene within the PAH catabolic region, has a modest 
sequence similarity (46%) with a known 1-hydroxy-2-naphthoate dioxygenase from Nocardioides 
sp. KP7 and has been annotated as such (Kim, 2008; Iwabuchi, 1998). 1-Hydroxy-2-naphthoate 
(12 in Scheme 2.3) is an intermediate that has been identified within the lower catabolic pathway 
of pyrene by M. vanbaalenii PYR-1. Other isolated metabolites for this lower pathway include 13, 
2-carboxybenzaldehyde, and phthalate which suggests that 12 is cleaved by a dioxygenase at the 
ortho position (Scheme 2.3). 1-Hydroxy-2-naphthoate dioxygenases typically cleave at the ortho 
position and requires ferrous iron (Iwabuchi, 1998). PhdI was purified and assayed for activity 
with 12 and cleavage of 12 at the ortho position was confirmed by product identification. Kinetic 
parameters were determined for this reaction and PhdI has a high kcat/KM value of 3.1 x 10
5 M-1s-1 
with 12. These data support the annotation of PhdI as a 1-hydroxy-2-naphthoate dioxygenase 
(Scheme 2.5).  
 
Scheme 2.5: Ring-opening of 1-hydroxy-2-naphthoate by PhdI.  
 
Due to the similarity of 12 and 1,2-dihydroxynaphthalene (7 in Scheme 2.2), PhdI might 
be the dioxygenase responsible for ring-opening of 7 in the naphthalene catabolic pathway of M. 
vanbaalenii PYR-1. 1,2-Dihydroxynaphthalene-1,2-diol (6, Scheme 2.2) and 2-hydroxybenzoate 
(11) were the only metabolites identified after growth of M. vanbaalenii PYR-1 in the presence of 
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naphthalene, suggesting that 7 is cleaved at the meta position. However, PhdI did not show ring-
opening activity when incubated with 7. PhdF is a dioxygenase putatively assigned to all ring-
cleavage reactions within the upper catabolic pathways for phenanthrene, pyrene, and fluoranthene 
by M. vanbaalenii PYR-1 (Kweon, 2007; Kim, 2007; Stingley, 2004). The location of the gene 
encoding PhdF (gene 0470) within the PAH catabolic region suggests that PhdF is a suitable 
alternative candidate for ring-opening of 7. PhdF was purified and assayed for ring-opening 
activity with 7 and no activity was observed. We have not identified a dioxygenase that is capable 
of cleaving 7, but there are six other annotated type I extradiol dioxygenases genes within the 
genome of M. vanbaalenii PYR-1 and three of these (genes 0545, 0591, and 4413) are also within 
the catabolic regions (Kim, 2008). It is possible that one of these dioxygenases is responsible for 
cleavage of 7. These dioxygenases will be the targets of future studies.  
 
The next step in the catabolism of 12 is the hydration of trans-carboxybenzylidenepyruvate 
(13 in Scheme 2.3) followed by a retro-aldol cleavage by a hydratase-aldolase. PhdJ is proposed 
to be the hydratase-aldolase that is active in the lower catabolic pathways of HMW PAHs, while 
PhdG has been proposed to function in the upper catabolic pathways (Kweon, 2007; Kim, 2007; 
Stingley, 2004). PhdJ and PhdG were assayed for hydratase-aldolase activity with 13 using a 
coupled assay and 13 alone. Both hydratase-aldolases converted 13 to 2-carboxybenzaldehyde, 
and the catalytic efficiencies for the coupled assays are consistent with those found using substrate 
alone. PhdJ has a kcat/KM that is 14-fold higher than that of PhdG and is likely the hydratase-
aldolase responsible for this reaction in vivo.  
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The product of meta-cleavage of 7 by a dioxygenase is 2-hydroxychromene-2-carboxylate 
(8, Scheme 2.2). Some bacteria utilize a glutathione-dependent isomerase to convert 8 to trans-
hydroxybenzylidenepyruvate (9) before processing by a hydratase-aldolase (Thompson, 2007). 
There is not a gene encoding a product with significant sequence similarity to a similar isomerase 
(NahD of the NAH7 plasmid in Pseudomonas putida G7) within the genome of M. vanbaalenii 
PYR-1 (Thompson, 2007). Moreover, mycobacteria do not produce glutathione (Anderberg, 
1998). There are several genes annotated as mycothiol-dependent isomerases within the genome 
of M. vanbaalenii PYR-1. Mycothiol-dependent isomerases utilize a thiol similarly to glutathione-
dependent isomerases and may be responsible for the isomerization of 8 to 9 in M. vanbaalenii 
PYR-1. It is also possible that the dioxygenase that cleaves 7 may function as an isomerase. We 
did not observe ring-opening of 7 by either of the dioxygenases (phdI or PhdF) purified in these 
experiments. PhdJ and PhdG were assayed for activity with 9 and both enzymes processed 9 to 
salicylaldehyde. The kcat/KM values for this reaction were comparable for PhdJ and PhdG. Hence, 
either PhdJ or PhdG could be responsible for cleavage of 9, but the activities of the enzymes have 
not been confirmed in vivo. The non-enzymatic isomerization of 8 to 9 could be sufficient for the 
reaction to proceed, PhdJ and PhdG could have an inherent isomerase activity, or the dioxygenase 
that cleaves 7 could also catalyze the isomerization of 8 to 9.  These possibilities will be 




Chapter 3: Investigation of the Ring-Cleaving Dioxygenase and Hydratase-
Aldolase Reactions in the M. vanbaalenii PYR-1 Phenanthrene Catabolic 
Pathway 
3.1 Introduction 
Phenanthrene is a polycyclic aromatic hydrocarbon (PAH) composed of three aromatic 
rings that displays various toxicities including disruption of nutritional and photosynthesis 
functions in maize, oxidative stress induction in guppies, and visual and cardiac developmental 
defects in zebrafish (Dupuy, 2015; Machado, 2014; Huang, 2013; Zhang, 2013). Phenanthrene is 
a model substrate for elucidation of various PAH catabolic pathways because its structure is similar 
to those of some carcinogenic HMW PAHs. Phenanthrene contains a bay-region (C-3 and C-4) 
and a K-region (C-9 and C-10) that are potential sites for epoxide formation by cytochrome p450 
enzymes (Scheme 3.1). Epoxide formation at these regions gives HMW PAHs carcinogenic 
properties (Seo, 2009). Elucidating the phenanthrene catabolic pathway is also important because 
many of the catabolic pathways for the more toxic HMW PAHs feed into the phenanthrene 
pathway (Kweon, 2011).  
 
Scheme 3.1: Epoxide formation at the Bay and K regions of phenanthrene. 
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The phenanthrene catabolic pathway has been most extensively studied in Mycobacterium 
vanbaalenii PYR-1 using metabolomic, proteomic, and genomic experiments (Moody, 2001; 
Stingley, 2004; Kim, 2005; Kim, 2008; Kweon, 2011). Phenanthrene catabolism by M. 
vanbaalenii PYR-1 involves the multiple routes shown in Scheme 3.2 (Stingley, 2004; Bayly, 
1966; Kweon, 2011). Degradation of phenanthrene begins with dioxygenation at the K-region to 
form 18, the bay-region to form 19 or the non-K and non-bay region (C-1 and C-2) to form 20 
(Scheme 3.2). Oxygenation at the non-K and non-bay region is thought to result in the methylated 
dead-end product 21 while 18 continues in the degradation pathway through ortho-ring cleavage 
to 22 and 19 continues through ortho- or meta-ring cleavage (23 and 24 respectively) (Kim, 2005). 
The meta-cleavage product 24 undergoes cis to trans isomerization (25), but it is unclear whether 
this isomerization is enzyme-catalyzed (a similar step in the naphthalene catabolic pathway is 
catalyzed by NAhD). Both the ortho- and meta-cleavage products are cleaved by a hydratase-
aldolase and the products (27 and 26, respectively) undergo another round of processing. These 
pathways result in the production of phthalate or salicylate that can be further degraded into TCA 
cycle intermediates to be used by the cell for energy production. Gene products have not been 



















Scheme 3.2: Proposed phenanthrene catabolism by M. vanbaalenii PYR-1. Brackets indicate 





The M. vanbaalenii PYR-1 gene 0470 encodes the iron-dependent type I extradiol 
dioxygenase PhdF that is upregulated in the presence of pyrene whose catabolic pathway 
ultimately intersects with phenanthrene’s through production of 3,4-dihydroxyphenanthrene (19) 
(Scheme 2.3) (Kim, 2007; Stingley, 2004). Stingley et al also showed that PhdF is likely involved 
in phenanthrene catabolism through the degradation route beginning with oxidation at positions 
C-3 and C-4 to produce 19 that is cleaved in the meta position to afford 24 (Stingley, 2004) 
(Scheme 3.3). Although M. vanbaalenii Pyr-1 can utilize the degradation route beginning with 19, 
the route beginning with 9,10-dihydroxyphenanthrene (18) is the preferred route for degradation 
of phenanthrene (Moody, 2001). This route involves the intradiol cleavage of 18 to produce 22. 
Cleavage at the intra- and extra-diol positions requires dioxygenases with different active-site 
residues and iron cofactors with different oxidation states, so it is highly unlikely that PhdF is 
responsible for the proposed meta-cleavage of 19 and the ortho-cleavage of 18 (Vaillancourt, 
2006). A previous study using Arthrobacter sp. P1-1 showed that 19 can also be cleaved in the 
ortho position and that 20 can be cleaved in both the ortho and meta positions rather than 
methylated and eliminated from the cell (Scheme 3.3) (Seo, 2006). It is possible that PhdF cleaves 
all three phenanthrene catechol compounds (18, 19, and 20) in either the ortho or the meta positions 
(Scheme 3.3) or is not responsible for cleavage of all three compounds.  
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Scheme 3.3: Possible ring-cleavage reactions of phenanthrene catechol compounds (18, 19, 20) 
and subsequent isomerization and/or hydrolysis.      
 
The M. vanbaalenii PYR-1 gene 0469 encodes the hydratase-aldolase PhdG that is also 
upregulated in the presence of pyrene. This, along with a study by Stingley et al, implicates PhdG 
in the phenanthrene degradation pathway involving 19. The activity of a hydratase-aldolase is not 
required for the phenanthrene degradation pathway involving 18. If M. vanbaalenii PYR-1 utilizes 
the pathway involving 20 for energy production, the product of ring-cleavage of 20 would be 
structurally similar to the product of ring-cleavage of 19 (Scheme 3.3) and it is likely that PhdG 
would be able to process both compounds.  
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A BLAST search reveals three M. vanbaalenii PYR-1 gene products with high sequence 
similarity to that of the type I extradiol dioxygenase 0470: 5306 with 39%, 4413 with 38%, and 
2891 with 38%. To date, none of these genes has been implicated in PAH catabolism, but all three 
are annotated as ring-cleaving dioxygenases and the 4413 gene is located within a catabolic gene 
cluster. All four ring-cleaving dioxygenases were cloned, expressed, purified, and assayed with 
the three proposed phenanthrene catechols (18, 19, and 20 in Scheme 3.3). The reaction products 
were purified and identified. The catechol compounds that did not act as substrates were also tested 
as inhibitors. The hydratase-aldolase PhdG was assayed for activity with the enzyme-catalyzed 
ring-opened catechols and the products were purified and identified.   
 
3.2 Experimental Procedures 
Materials 
Chemicals, biochemicals, buffers, and solvents were purchased from Sigma-Aldrich 
Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), Fluka Chemical Corp. 
(Milwaukee, WI), or EMD Millipore, Inc. (Billerica, MA). 2,3-Dihydroxybiphenyl (99%) was 
purchased from Wako Chemicals Inc. (Richmond, VA). 3-Methylcatechol, 9,10-
phenanthrenequinone, 2,3-dimethoxybenzaldehyde, 3,4-dimethoxybenzaldehyde, and 3,4-
dimethoxybenzoic acid were purchased from Sigma-Aldrich Chemical Co. The synthetic 
procedures for 1,2-dihydroxyphenanthrene (20), 2,3-dihydroxyphenanthrene, 3,4-
dihydroxyphenanthrene (19), and 9,10-dihydroxypheananthrene (18) are reported in the 
supplemental material (Section 3.5). The DEAE-Sepharose resin and the prepacked PD-10 
Sephadex G-25 columns were obtained from GE Healthcare (Piscataway, NJ). The HisPur Ni-
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NTA resin was purchased from Sigma-Aldrich Chemical Co. The EconoColumn® 
chromatography columns were obtained from BioRad (Hercules, CA). The Amicon stirred cell 
concentrators, ultrafiltration membranes (10,000 Da cutoff), and Amicon Ultra centrifuge 
concentrators (3000 Da cutoff) were purchased from EMD Millipore Inc.  
 
Bacterial Strains, Plasmids and Enzymes 
The pET vectors were obtained from Novagen (Madison, WI). Escherichia coli strain 
C41(DE3) was obtained from Sigma-Aldrich Chemical Co. Isolated genomic DNA from 
Mycobacterium vanbaalenii PYR-1 and Mycobacterium vanbaalenii PYR-1 gene 4413 in pET17b 
were obtained from the laboratory of Dr. Carl Cerniglia (National Center for Toxicology Research, 
U.S. Food and Drug Administration, Jefferson, AR).  
 
General Methods 
Oligonucleotide primers were synthesized by Sigma-Aldrich Co. The PCR amplification 
of DNA sequences was conducted in a GeneAmp 2700 thermocycler (Applied Biosystems, 
Carlsbad, CA). The GenElute gel extraction was purchased from Sigma-Aldrich Co. Enzymes and 
reagents used for in these procedures were purchased from New England Biolabs, Inc (Ipswich, 
MA). DNA sequencing was performed in the DNA Core Facility in the Institute for Cellular and 
Molecular Biology (ICMB) at the University of Texas at Austin. The QIAprep spin miniprep kit 
was purchased from Qiagen (Hilden, Germany). Sonication was performed using a W385 
sonicator from Heat systems-ultrasonics, Inc. (Farmingdale, NY). Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was carried out on a Bio-Rad Mini-Protean II 
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gel electrophoresis apparatus. Protein concentrations were determined using the Bradford method 
(Bradford, 1976). Electrospray ionization mass spectrometry (ESI-MS) was carried out on an LCQ 
electrospray ion-trap mass spectrometer (Thermo, San Jose, CA) housed in the ICMB Protein and 
Metabolite Analysis Facility at the University of Texas. Steady-state kinetic assays were 
performed on an Agilent 8453 diode-array spectrophotometer (Agilent Technologies, Santa Clara, 
CA). Nonlinear regression data analysis was performed using the program Grafit (Erithacus 
Software Ltd., Staines, U.K.). Nuclear magnetic resonance (NMR) spectra were recorded on a 
Varian UNITY+ 300 MHz spectrometer (Palo Alto, CA) or a Bruker AVANCE III 500 MHz 
spectrometer (Billerica, MA). NMR signals were analyzed using the software program SpinWorks 
3.1.6 (Copyright 2009 Kirk Marat, University of Manitoba). 
 
Cloning of M. vanbaalenii PYR-1 genes 2891 and 5306 
Amplification of the desired genes was achieved through two rounds of PCR. The first 
round used overhang PCR primers that annealed within 100 bp around the desired gene. The 
second round isolated the desired gene flanked with appropriate restriction sites. The primers used 
for PCR are shown in Table 3.1. The 100 µL amplification reaction contained the M. vanbaalenii 
PYR-1 genomic DNA as a template (15 ng), dNTPs (0.4 mM), MgCl (2 mM), primers (0.4 µM), 
1× buffer, and Vent Polymerase (1 unit). The PCR amplification protocol consisted of a 5 min 
denaturation step at 94°C followed by 35 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 
3 min and ended with a 10 min elongation step at 72°C.  The PCR reaction product size was 
confirmed using a 1% agarose gel and isolated using a GenElute gel extraction kit and elution into 
60 µL of water. The second round of PCR was set up and run identically to round one except 5 µL 
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of round one PCR product was used as template DNA and the primers containing restriction sites 
were used. The product was purified as described above. The PCR products were inserted into 
pET44 or pET32 between appropriate restriction sites (Table 3.1) using digestion and ligation 
procedures reported elsewhere (Deininger, 1990). An aliquot of the ligation mixture (30 µL) was 
transformed into E. coli C41(DE3) using a calcium heat shock method (Deininger, 1990). 
Transformed cells were grown on agar plates containing ampicillin (100 µg/mL) at 37 °C 
overnight. A single colony was used for the generation of additional plasmid for sequencing and 
protein expression. 
 
Table 3.1: Primers and restriction enzymes used for PCR amplification of M. vanbaalenii PYR-1 
dioxygenase genes. 
 
Expression of 0470 (PhdF), 2891, 4413, and 5306 
LB cultures (25 mL) containing ampicillin (100 µg/mL) were inoculated using a single 
colony and grown overnight at 37 °C. LB cultures (4 × 400 mL) were then inoculated using an 
appropriate amount of the overnight culture to make OD600 = 0.05 AU and grown at 37°C for 2.5 
h. Protein expression was induced overnight (18 h) at 21 °C using a final isopropyl-β-D-
thiogalactoside concentration of 0.1 mM. Cells were harvested by centrifugation (10,000 × g) with 
yields ranging from 3-5 g and stored at −80 °C. 
Gene Overhang Primers Fwd Overhang Primers Rev Round 2 Primers Fwd Round 2 Primers Rev Vector
PhdF TGGGCCGCACTC TTAGGAACCGGA GGACAGCACGAA GCCGTCGAGAAG EcoRI HindIII pET32
CAGCAGCGCTAT TCGCCATTTCAC TTCTTGGTGAA CTTTCATGTTG
2891 TGGTCCCAGTGC CGATGATCTGAC GTCGGGCAGGAG TGTCGGTGCAAG SacI HindIII pET44
GTGATCT GGGGTCG CTCAGTCTGATC CTTTCACGGACG
5306 GAACTGCCCCAGC TTTCCTCGGAGG ATAGTTCGGATC GAGGACAAAGCT BamHI HindIII pET32
ACATTCC GGGATAGTT CACGATCAAG TCTAGGATTT
4413 ― ― ― ― NdeI XhoI pET17
Restriction Enzymes
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Purification of Enzymes 
0470, 2891, and 5306 
Cells were suspended to a final concentration of 10 mg/mL in Buffer A (20 mM HEPES, 
300 mM NaCl, pH 7) with 15 mM imidazole. Cells were disrupted by sonication and the resulting 
solution was centrifuged for 30 min at 17,700 × g and 4 °C. The supernatant was loaded onto a Ni-
NTA column (1 × 10 cm, ~6 mL resin) pre-equilibrated with Buffer A + 15 mM imidazole. The 
column was washed with Buffer A + 70 mM imidazole and the desired protein was eluted with 
Buffer A + 90 mM imidazole. Protein purity was confirmed by SDS-PAGE by the presence of a 
single band at the correct molecular mass after staining using Coomassie Blue. The eluant was 
concentrated to ~1 mg/mL and exchanged into 20 mM HEPES, 300 mM NaCl, 5% glycerol, pH7 
(Buffer B) using an Amicon stirred cell concentrator (10,000 MW cutoff). 
 
4413 
Cells were suspended in Buffer A to a concentration of 10 mg/mL, lysed by sonication and 
the resulting solution was centrifuged for 30 min at 17,700 × g and 4 °C. The clarified supernatant 
was loaded onto a DEAE-Sepharose column (1 × 10 cm, ~8 mL resin) pre-equilibrated with Buffer 
A. The column was washed with 20 mL of Buffer A followed by a linear salt gradient (0–0.5 M 
NaCl, 200 mL total). Pure protein typically elutes at 0.3 M NaCl as determined by activity assays 
and SDS-PAGE. Protein purity was confirmed by SDS-PAGE by the presence of a single band 
after staining using Coomassie Blue. The protein-containing fractions were combined and 
concentrated to ~1 mg/mL and exchanged into Buffer B using an Amicon stirred cell concentrator 
(10,000 MW cutoff). 
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Activation of 0470 (PhdF), 2891, 4413, and 5306 
To activate the enzymes, ascorbate (4 mM final concentration), Iron(II) chloride (2 mM 
final concentration) and acetone (5% final concentration) were added to aliquots (~500 uL) of 
protein purified as described above and the resulting mixture was incubated on ice for 30 min. The 
sample was centrifuged for 5 min at 20,800 × g and exchanged into Buffer B using a PD-10 
column. Activity decreases within 8 h of activation so protein is activated and assayed on the same 
day.  
 
Steady-State Kinetic Analysis Using Dioxygenases 
For kinetic analysis, enzymes were kept on ice to slow deactivation. Aliquots of enzyme 
were added to 1 mL 20 mM HEPES at pH 7.0 to final enzyme concentrations ranging from 20 nM 
to 1 µM for PhdF, 100 nM to 300 nM for 2891, 70 nM to 1 µM for 4413, and 41 nM to 1.3 µM 
for 5306 as determined by the Bradford method (Bradford, 1976). The reaction was initiated by 
the addition of 1-20 µL of substrate in ethanol from stock solutions of 3-methylcatechol (20 – 175 
mM), 2,3-dihydroxybiphenyl (1 – 4.5 mM), 3,4-dihydroxyphenanthrene (0.7 – 6 mM), and 1,2-
dihydroxyphenanthrene (2 mM). Final substrate concentrations are summarized in Table 3.2.  UV 
spectroscopy was used to monitor the reactions as follows: for 3-methylcatechol, monitor the 
increase in absorbance at 388 nm (ε = 13,800 M−1 cm−1); for 2,3-dihydroxybiphenyl, monitor the 
increase in absorbance at 434 nm (ε = 21,700 M−1 cm−1); for 3,4-dihydroxyphenanthrene, monitor 
the decrease in absorbance at 245 nm (ε = 25,800 M−1 cm−1); and for 1,2-dihydroxyphenanthrene, 
monitor the decrease in absorbance at 263 nm (ε = 32,800 M−1 cm−1). Initial rates were determined 
from the first 15 s of the reaction, plotted versus substrate concentration, and fit to the Michaelis-
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Menten or substrate-inhibition equations to calculate the steady-state parameters kcat, KM, and Ki 
using Grafit (Johnson, 2011, Haldane, 1930). PhdF, 2891, 4413, and 5306 showed no enzymatic 








Identification of Dioxygenase Reaction Products 
2,3-Dihydroxybiphenyl, 3,4-Dihydroxyphenanthrene, and 1,2-Dihydroxyphenanthrene 
PhdF was used to generate the ring-opened products of 2,3-dihydroxybiphenyl (2,3-DHB) 
and 3,4-dihydroxyphenanthrene (3,4-DHP) (30 and 25 respectively, Scheme 3.4). The enzyme 
2891 was used to generate the 1,2-dihydroxyphenanthrene (1,2-DHP) cleavage product (32 in 
Scheme 3.4). PhdF was also used to generate the 3-methylcatechol ring-opened product (28) in 
order to validate and optimize the product purification methodology. The products were identified 
by UV spectroscopy, derivatization, and NMR spectroscopy.  
 
Scheme 3.4: Reaction products were generated and isolated as described in the text and converted 
to the indicated stable compounds for analysis. 
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After expression of the enzymes as described above, the cells were centrifuged at 17,700 
× g for 30 min. The cell pellet was washed 3 times by resuspension in Buffer A (OD600 = 0.5 for 
10 µL suspension in 1 mL buffer) and then centrifuged (17,700 × g for 30 min). The pellet was 
then resuspended in Buffer A to an OD600 of 0.5 for 10 µL PhdF in 1 mL of buffer and an OD600 
of 0.5 for 40 µL of 2891 in 1 mL buffer. The final volume was 100 mL for the 2,3-DHB reaction, 
300 mL for the 3,4-DHP reaction, and 600 mL for the 1,2-DHP reaction. Stock substrates were 
prepared in ethanol immediately before use at concentrations of 50 mg/mL. An aliquot of the stock 
substrate (2 mL) was added to the cell suspension, which was stirring on ice, over the course of 5 
min to final concentrations of 1 mg/mL for 2,3-DHB, 0.33 mg/mL for 3,4-DHP, and 0.17 mg/mL 
for 1,2-DHP. Every 5 min, aliquots (500 µL) were removed, centrifuged at 20,800 × g for 2 min, 
and the cell free supernatant monitored by UV spectroscopy until the reaction was complete (~30 
min) as determined by no further change in absorbance. The reactions were monitored as follows: 
for 2,3-dihydroxybiphenyl, monitor the increase in absorbance at 434 nm; for 3,4-
dihydroxyphenanthrene, monitor the decrease in absorbance at 245 nm; and for 1,2-
dihydroxyphenanthrene, monitor the decrease in absorbance at 263 nm. The reaction was 
centrifuged at 17,700 x g for 20 min and the cell-free supernatant acidified to a pH of 2.25 using 
drops of 10 M HCl. The acidic solutions were extracted using 2.5 volumes of ether and the 
collected ether layers were dried over anhydrous magnesium sulfate. The unstable reaction 
products were methylated using diazomethane generated using a Diazald kit following the 
manufacturer’s instructions (Scheme 3.4). The methylated products were purified on a silica 
column using 2:1 hexane:ethyl acetate for 31 and 4:1 hexanes:ethyl acetate for 33 and 35 (Scheme 
3.4). The product-containing fractions, as determined by TLC, were combined and evaporated to 
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dryness. The products were analyzed using ESI-MS. The masses were consistent with the 
calculated masses (255.24 Da for 31 and 256.28 Da for 33 and 34). The methylated products were 
resuspended in ~0.6 mL of CDCl3 and placed in an NMR tube. 
1H NMR and/or 13C NMR 
spectrums were obtained for each product. 31: 1H NMR (CDCl3, 300 MHz) δ 3.9 (3H, s), 6.4 (1H, 
dd, J = 0.6 Hz, 11.7 Hz), 6.5 (1H, s), 7.1 (1H, dd, J = 0.6 Hz, 15.3 Hz), 7.5 (3H, m), 7.9 (1H, dd, J 
= 11.7 Hz, 15.3 Hz), 7.9 (2H, m); 13C NMR (CDCl3, 75 MHz) δ 53.5, 109.4, 127.2, 128.45, 128.6, 
132.8, 137.0, 138.0, 144.7, 165.1, 190.5. 34: 1H NMR (CDCl3, 300 MHz) δ 3.9 (3H, s), 6.4 (1H, 
dd, J = 0.7 Hz, 11.7 Hz), 7.1 (1H, dd, J = 0.6 Hz, 15.3 Hz), 7.5 (2H, m), 7.58 (1H, m), 7.87 (1H, 
dd, J + 11.7 Hz, 15.3 Hz), 7.97 (2H, m); 13C NMR (CDCl3, 75 MHz) δ 169.8, 145.8, 134.9, 127.8, 
127.6, 127.0, 126.0, 124.7, 124.5, 122.0, 121.8, 117.7, 113.6, 94.0, 54.1. 33: 1H NMR (CDCl3, 
300 MHz) δ 3.97 (3H, s), 4.47 (1H, s), 6.03 (1H, d, J = 10.0 Hz), 7.2 (1H, d, J = 8.9 Hz), 7.43 (1H, 
m), 7.55 (1H, m), 7.61 (1H, d, J = 9.7 Hz), 7.8 (2H, m), 8.08 (1H, dd, J = 8.7 Hz, 0.6 Hz); 13C 
NMR (CDCl3, 75  MHz) δ 169.7, 148.5, 130.6, 129.9, 129.9, 128.8, 127.3, 124.5, 122.9, 121.4, 
118.0, 117.7, 112.1, 93.5, 54.1. 
 
3-Methylcatechol 
PhdF was used to generate the ring-opened product for 3-methylcatechol (3-MC) (28 in 
Scheme 3.4). Protein was expressed as described above and cells were resuspended in Buffer A at 
a concentration of 1 mg / 30 mL. The cells were disrupted via sonication and the resulting solution 
was centrifuged for 30 min at 17,700 × g and 4C. The clarified supernatant was mixed with 3-MC 
and the product was converted to the picolonic acid derivative (29) for isolation and purification. 
Briefly, 80 tubes containing 2 mL Buffer A, 100 µL of clarified supernatant, and 40 µL of 22 
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mg/mL 3-MC in ethanol were incubated at room temperature for ~20 min. Ammonium sulfate (2 
mL of 4 mM stock solution) was added to each tube and the tubes were combined and extracted 
with methanol. The extract was mixed with silica, concentrated in vacuo, washed with 10% 
methanol in chloroform, and the product was recovered using 9:3:1 chloroform:methanol:acetic 
acid. The solution was evaporated to dryness and the product resuspended in ~0.6 mL of CDCl3 
and placed in an NMR tube. A 13C NMR spectrum was obtained and matched that of authentic 29. 
29: 1H NMR (D2O, 300 MHz) δ 2.4 (3H, s), 7.2 (1H, d, J = 8.1 Hz), 7.5 (1H, d, J = 7.8 Hz), 7.7 
(1H, t). 
 
Inhibition of PhdF  
The inhibition of PhdF by 1,2-dihydroxyphenanthrene (1,2-DHP), 2,3-
dihydroxyphenanthrene (2,3-DHP), and 9,10-dihydroxyphenanthrene (9,10-DHP) was determined 
as follows. The enzyme (1 mg/mL) was incubated with an excess of compound dissolved in ethanol 
(10 mM final concentration) in Buffer B (1 mL) for 30 min at 22 °C. In a separate control 
experiment, the same quantity of PhdF was incubated without inhibitor under otherwise identical 
conditions. The reaction was exchanged into Buffer B using an Amicon Ultra-0.5 mL centrifugal 
filter to remove unbound compounds. The washed enzymes were assayed for residual activity. 
Samples treated with 1,2-DHP, 2,3-DHP, or 9,10-DHP had no activity while the control sample 
retained full activity. The four samples were exchanged into 20 mM ammonium carbonate using 




PhdG Activity and Product Identification 
The gene 0469 was cloned and the protein PhdG was expressed and purified as described 
in Chapter 2. Activity of PhdG with 25 (Scheme 3.3) was analyzed by mixing PhdF (0.30 µM final 
concentration) and PhdG (0.9 µM final concentration) in 1 mL of 20 mM HEPES buffer at pH 7. 
The reaction was initiated with the addition of 3,4-DHP in ethanol (40 µM final concentration) 
and monitored using UV spectroscopy until the absorbance at 392 nm no longer increased. The 
product, 26, was extracted with 3 volumes of ethyl acetate and purified using a silica gel column 
with elution by ethyl acetate. The collected fractions were evaporated to dryness and the residue 
analyzed by ESI-MS. Activity of PhdG with 32 (Scheme 3.3) was analyzed by mixing 2891 (1 µM 
final concentration) and PhdG (0.9 µM final concentration) in 1 mL 20 mM HEPES buffer at pH 
7. The reaction was initiated by the addition of 1,2-DHP dissolved in ethanol (40 µM final 
concentration) and monitored by UV spectroscopy. PhdG showed no activity when incubated with 
32.  
 
Steady-State Kinetic Analysis Using PhdG 
A coupled assay was used to determine kinetic parameters for PhdG with 25. An aliquot 
of PhdF, prepared as described above, was added to Buffer A (1 mL) to give a final concentration 
of 1 µM. Aliquots (0.2 – 20 µL) of 3,4-dihydroxyphenanthrene in ethanol (1 mM stock) were 
added and the reaction was monitored using UV spectroscopy until completion as determined by 
no further decrease at 245 nm. This process generates 25. An aliquot (3 µL, 0.6 µM final) of PhdG 
prepared as described in Chapter 2 was added to the solution and the increase in absorbance at 392 
nm (ε = 3,768 M−1 cm−1) was used to monitor the reaction. Initial rates were determined from the 
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first 15 s of the reaction, plotted versus substrate concentration, and fit to the substrate inhibition 
equation to calculate the steady-state parameters kcat, KM, and Ki using Grafit (Haldane, 1930). 
 
3.3 Results 
Steady-State Kinetic Analysis Using Dioxygenases 
The kobs vs substrate concentration was plotted for the reactions of all four dioxygenase 
enzymes with 3-methylcatechol (3-MC), 2,3-dihydroxybiphenyl (2,3-DHB), 1,2-
dihydroxyphenanthrene (1,2-DHP), and 3,4-dihdroxyphenanthrene (3,4-DHP). The plots are 
shown in Table 3.3. The reactions using 2891 and 2,3-dihydroxybiphenyl and 3,4-
dihydroxyphenanthrene and 4413 and 3,4-dihydroxyphenanthrene display substrate inhibition and 
the data are fit using the substrate inhibition equation (Haldane, 1930). All other reactions appear 
to obey classic Michaelis-Menten kinetics and the data are fit using the Michaelis-Menten equation 
(Johnson, 2011). It is possible that some of the reactions assumed to follow classic Michaelis-
Menten kinetics may display substrate inhibition if it were possible to assay using higher substrate 
concentrations, specifically the reactions of 2891 with 3-methylcatechol and 1,2-
dihydroxyphenanthrene. Higher substrate concentrations are precluded by absorbance values 
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When 2,3-dihydroxyphenanthrene (2,3-DHP) or 9,10-dihydroxyphenanthrene (9,10-DHP) 
was incubated with each enzyme for >30 min no spectral changes other than non-enzymatic 
oxidation were observed suggesting that these compounds might not be substrates for any of the 
four enzymes. It should be noted that the rate of non-enzymatic oxidation of 9,10-
dihydroxyphenanthrene to quinone is faster than the non-enzymatic oxidation of the other 
phenanthrene compounds and makes 9,10-dihydroxyphenanthrene difficult to assay. When 1,2-
dihydroxyphenanthrene was incubated with PhdF or 4413 for >30 min no spectral changes other 
than non-enzymatic oxidation were observed suggesting that 1,2-dihydroxyphenanthrene might 
not be a substrate for PhdF or 4413. 1,2-Dihydroxyphenanthrene was processed by 2891 and 5306 
and the absorbance spectrum for the reaction with 2891 is shown in Figure 3.1B. 3,4-
Dihydroxyphenanthrene was processed by all four enzymes and the absorbance spectrum for the 
reaction of 3,4-dihydroxyphenanthrene and PhdF is shown in Figure 3.1A. Product identification 











Figure 3.1: Absorbance spectra for A) the reaction of PhdF and 3,4-dihydroxyphenanthrene and 
B) the reaction of 2891 and 1,2-dihydroxyphenanthrene. 
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1,2-Dihydroxyphenanthrene and 3,4-dihydroxyphenanthrene undergo non-enzymatic 
oxidation to a quinone species accompanied by a spectral shift identical to that of the enzymatic 
ring-cleavage reactions. The rate of the non-enzymatic oxidation to quinone for these two 
substrates was determined for all substrate concentrations assayed. If the non-enzymatic oxidation 
rate is less than 10% of the enzymatic reaction rate, then the non-enzymatic rate is considered 
insignificant and ignored. If the non-enzymatic oxidation rate is higher than 10% of the enzymatic 
reaction rate, then the difference between the enzymatic reaction rate and the non-enzymatic 
oxidation rate is used for analysis.   
 
For all four enzymes, the highest kcat/KM was measured using 3,4-dihydroxyphenanthrene 
as the substrate. Extradiol dioxygenases are typically efficient enzymes with kcat/KM values ranging 
up to 1x106 M-1s-1.71 The kcat/KM for the enzymes studied here show comparable efficiencies only 
with 3,4-dihydroxyphenanthrene as the substrate. Kinetic parameters are summarized in Table 3.4.  
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 Table 3.4: Steady-state kinetic parameters for dioxygenases kinetic assays. 
 
Identification of Dioxygenase Reaction Products  
To determine whether cleavage by the dioxygenases occurs at the ortho or meta position 
the products of each reaction were purified and identified. 3-Methylcatechol, 2,3-
dihydroxybiphenyl, and 3,4-dihydroxyphenanthrene were treated with whole cell suspensions of 
PhdF, and 1,2-dihydroxyphenanthrene was treated with whole cell suspensions of 2891. The 
reaction product 28 was converted to picolinic acid and the reaction products 30, 32, and 25 were 
converted to stable, methylated compounds (Scheme 3.4) that were purified and identified using 
ESI-MS and 1H and/or 13C NMR spectroscopy. All dioxygenases assayed cleaved substrates at the 
meta position. Ring-opening of 3,4-dihydrxoyphenanthrene (19) results in a product in the trans 
Enzyme Substrate k cat  (s
-1




) K i  (µM)
PhdF 3-methylcatechol 0.32 ± 0.01 50 ± 6 6.5E+03 ± 0.9E+03 NA
2,3-dihydroxybiphenyl 0.168 ± 0.002 <10.8 >1.5e+04 NA
1,2-dihydroxyphenanthrene NA NA NA NA
3,4-dihydroxyphenanthrene 9.3 ± 0.9 1.7 ± 0.5 6.0E+06 ± 2.0E+06 NA
2891 3-methylcatechol 0.52 ± 0.07 1300 ± 300 5.0+E02 ± 1.0+E02 NA
2,3-dihydroxybiphenyl 60 ± 20 180 ± 80 5E+05 ±3E+05 150 ± 70
1,2-dihydroxyphenanthrene 0.32 ± 0.01 10 ± 1 3.4E+04 ± 0.6E+04 NA
3,4-dihydroxyphenanthrene 9 ± 2 10 ± 4 1.2E+06 ± 0.7E+06 40 ± 20
4413 3-methylcatechol 19.2 ± 0.7 510 ± 80 3.9E+04 ± 0.7E+04 NA
2,3-dihydroxybiphenyl 1.09 ± 0.02 28 ± 2 4.0E+04 ± 0.4E+04 NA
1,2-dihydroxyphenanthrene NA NA NA NA
3,4-dihydroxyphenanthrene 640 ± 80 150 ± 20 5.0E+06 ± 1.0E+06 90 ± 10
5306 3-methylcatechol 0.135 ± 0.007 700 ± 100 2.2E+02 ± 0.6E+02 NA
2,3-dihydroxybiphenyl 2.2 ± 0.7 15 ± 1 1.5E+05 ± 0.2E+05 NA
1,2-dihydroxyphenanthrene 0.058 ± 0.003 12 ± 2 5.0E+03 ± 1.0E+03 NA
3,4-dihydroxyphenanthrene 8.9 ± 0.6 4.2 ± 0.9 2.3E+06 ± 0.6E+06 NA
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form (25) while ring-opening of 1,2-dihydroxyphenanthrene (20) results in a product in the cis 
form (32).  
 
Inactivation of PhdF and Mass Spec Analysis 
In view of the observation that the reaction of PhdF and 3,4-dihydroxyphenanthrene has a 
high kcat/KM, but PhdF does not process 1,2-DHP, 2,3-DHP, or 9,10-DHP, all of which are 
structural isomers of 3,4-DHP, we examined the ability of 1,2-DHP, 2,3-DHP, and 9,10-DHP to 
function as inhibitors of PhdF. After aerobic incubation of PhdF with excess of either 1,2-DHP, 
2,3-DHP, or 9,10-DHP at 22 °C for 30 min, all enzyme activity was lost. Removing the inhibitor 
does not restore PhdF activity. In the absence of the inhibitors, the same protocol does not result 
in a reduction of PhdF activity. To determine whether 1,2-DHP. 2,3-DHP, or 9,10-DHP had 
covalently modified the enzyme, mass spec analysis was performed on samples of inhibited PhdF 
and compared to the active PhdF control. Analysis did not show a mass difference between the 
inhibited and control samples, suggesting that the inhibitors do not covalently modify PhdF.  
 
Identification of PhdG Reaction Products 
PhdG converts 25 to 26 but does not process 35 (Scheme 3.5). The UV spectrum 
corresponding to the reaction of PhdG, PhdF and 3,4-dihydroxyphenanthrene (19) is shown in 
Figure 3.2. The product 26 was isolated and the mass was determined. The mass (172.05 Da) is 




Scheme 3.5: Proposed reaction of PhdG with A) the reaction product of PhdF and 3,4-
dihydroxyphenanthrene and B) the reaction product of 2891 and 1,2-dihydroxyphenanthrene. 




Figure 3.2: Absorbance spectrum of the reaction of PhdF, PhdG and 3,4-dihydroxyphenanthrene. 
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Steady-State Kinetic Analysis Using PhdG 
A coupled assay with PhdF, 3,4-dihydroxyphenanthrene (19), and PhdG was used to 
determine the kinetic parameters for PhdG with 25. The absorbance spectrum of the reaction is 
shown in Figure 3.3. A plot of kobs vs 3,4-dihydroxyphenanthrene concentration is shown in Figure 
3.4. The reaction displayed substrate inhibition and the data were fit to the substrate inhibition 
equation (Haldane, 1930). The kinetic parameters are given in Table 3.5.  
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Figure 3.3: Absorbance spectrum of A) the reaction of PhdF and 3,4-dihydroxyphenanthrene (19) 






Figure 3.4: Plot of kobs vs 3,4-dihydroxyphenanthrene (19) concentration for the reaction of PhdG 













Our overall goal in this chapter is to provide biochemical evidence for proposed reactions 
in the phenanthrene catabolic pathway of M. vanbaalenii PYR-1. Specifically, we wanted to 
identify the ring-opening dioxygenase and hydratase-aldolase enzymes that act in this pathway 
and determine whether an isomerase is required.  
 
PhdF has been previously annotated as a type I extradiol dioxygenase that catalyzes the 
ring-opening of 3,4-dihydroxyphenanthrene (19) in the meta position (Scheme 3.2) during 
catabolism of phenanthrene and pyrene by M. vanbaalenii PYR-1 (Stingley, 2004; Kim, 2007). 
Catabolism of phenanthrene by M. vanbaalenii PYR-1 also produces 9,10-dihydroxyphenanthrene 
(18), which is ring-opened in the ortho position and 1,2-dihydroxyphenanthrene (20), which is 
methylated and eliminated from the cell (Scheme 3.2) (Stingley, 2004; Kweon, 2011). Studies 
using other bacteria show that 3,4-dihydroxyphenanthrene can also be ring-opened in the ortho 
position and that 1,2-dihydroxyphenanthrene can be ring-opened at the ortho or meta position 
instead of being methylated and eliminated from the cell (Seo, 2006). We examined the activity of 
PhdF with 3,4-dihydroxyphenanthrene, 9,10-dihdyroxyphenanthrene, and 1,2-
dihydroxyphenanthrene. In our hands, PhdF did not ring-open 9,10-dihydroxyphenanthrene or 1,2-
dihydroxyphenanthrene but did ring-open 3,4-dihydroxyphenanthrene with a kcat/KM of 4 x 10
6 M-
1s-1. The product of the reaction of PhdF with 3,4-dihydroxyphenanthrene was identified as 25 
(Scheme 3.2) which confirms the proposed ring-opening activity of PhdF in the meta position in 
this pathway (Scheme 3.6). It is likely that PhdF is active in the catabolic pathway of phenanthrene 
that begins with oxidation at the C-3 and C-4 positions.  
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The inhibition of extradiol ring-cleaving dioxygenases has been well-studied (Vaillancourt, 
2006). Inhibition can be achieved through covalent modification of active site residues, but the 
more accepted mechanism of inhibition is oxidation of the active site iron (Vaillancourt, 2006).  
After a substrate or inhibitor enters the active site a solvent molecule bound to the iron is displaced 
allowing oxygen to enter the active site. A superoxide is formed that can oxidize the ferrous iron 
to ferric iron (Cho, 2010). Extradiol ring-cleaving dioxygenases require ferrous iron for activity 
(Vaillancourt, 2006). We tested 9,10-dihydroxyphenanthrene and 1,2-dihydroxyphenanthrene for 
their ability to inhibit PhdF. Our results indicate that both compounds irreversibly inactivate PhdF 
in a non-covalent manner. Further tests, including substrate protection studies and/or determination 
of the presence of and ionization state of the active-site iron in the presence of the inhibitor, will 
be carried out in future work in order to determine the mechanism of inactivation. The dead-end 
pathway utilized by M. vanbaalenii PYR-1 after production of 1,2-dihydroxyphenanthrene could 
be a means of preventing inactivation of PhdF by 1,2-dihydroxyphenanthrene.   
 
To identify a dioxygenase that potentially functions in the catabolic pathways of 1,2-
dihydroxphenanthrene (20 Scheme 3.2) and 9,10-dihydroxphenanthrene (18) we assayed three 
other putative type I extradiol dioxygenases in the M. vanbaalenii PYR-1 genome with moderate 
sequence similarity to PhdF (38-39%). These putative dioxygenases are products of the genes 
2891, 4413, and 5306. All three gene products ring-opened 3,4-dihydroxyphenanthrene through 
cleavage at the meta position (19, Scheme 3.2), and the gene products of 2891 and 4413 display 
substrate inhibition with this compound. Mechanism-based substrate inhibition is well-
documented for extradiol dioxygenases (Vaillancourt, 2006). None of the three dioxygenases ring-
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opened 9,10-dihydroxyphenanthrene, but the products of 2891 and 5306 ring-opened 1,2-
dhydroxyphenanthrene through cleavage at the meta position.  These three genes are not 
upregulated during the catabolism of pyrene, a process that generates 3,4-dihydroxyphenanthrene 
as an intermediate, so it seems unlikely that any of these dioxygenases are responsible for cleavage 
of 3,4-dihydroxyphenanthrene during phenanthrene catabolism by M. vanbaalenii PYR-1. 
Although no intermediates that would be produced in the catabolism of 1,2-
dihydroxyphenanthrene via an energy-producing pathway have been isolated, if such a pathway is 
utilized by M. vanbaalenii PYR-1 (possibly under conditions differing from those used in previous 
studies) the gene products of either 2891 or 5306 may be active within this pathway. A 
dioxygenase has not been identified that is capable of cleavage of 9,10-dihydroxyphenanthrene. 
The gene encoding protocatechuate-3,4-dioxygenase is the only annotated intradiol dioxygenase 
gene within the M. vanbaalenii PYR-1 genome and the gene product is responsible for ortho-
cleavage of protocatechuate. It is possible that this enzyme is responsible for cleavage of both 
protocatechuate and 9,10-dihydroxyphenanthrene. This will be the subject of a future study.  
 
In addition to these questions, we are interested in determining whether an isomerase is 
required to isomerize the ring-opened products before they are further processed by a hydratase-
aldolase. There is not a gene within the PAH catabolic gene clusters that has significant sequence 
similarity with a glutathione-dependent isomerase (NahD in Pseudomonas putida G7) known to 
be active within the naphthalene catabolic pathway (Kim, 2008). Also, mycobacteria are inhibited 
by the presence of glutathione and do not utilize this compound (Anderberg, 1998). PhdG, a 
hydratase-aldolase proposed within the phenanthrene catabolic pathway of M. vanbaalenii PYR-
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1, was assayed for activity with the product of the reaction of PhdF and 3,4-
dihydroxyphenanthrene directly (Scheme 3.5A). PhdG cleaves this product (25) without the need 
for an isomerase and the product of this reaction was identified as 26 (Scheme 3.6). This suggests 
that either the non-enzymatic isomerization of 24 to 25 is sufficient or that the dioxygenase can 
catalyze the isomerization and no isomerase is required. PhdG was also assayed for activity with 
the product of the reaction of 2891 and 1,2-dihydroxyphenanthrene (Scheme 3.5B). PhdG did not 
process the ring-cleaved product. If the non-enzymatic isomerization of 24 to 25 is sufficient then 
it is unlikely that an isomerase would be required for the transformation of 32 to 35. If the 
isomerization of 32 to 35 occurs non-enzymatically it is possible that 35 either cannot enter the 
active-site of PhdG or it binds the active-site of PhdG in a non-productive fashion. If the ring-
cleaving dioxygenase is responsible for the isomerization of 24 to 25 then it is possible that the 
dioxygenase cannot catalyze the isomerization of 32 to 35 and that 32 is not a substrate for PhdG. 
Further studies such as inhibition assays and/or crystal structure determination of PhdG with 25 
and isomerase activity assays of the dioxygenases with the ring-opened products 24 and 32 can 
clarify this issue.    
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Scheme 3.6: Reactions analyzed in this experiment. Bold arrows indicate confirmed reactions.  
 
Overall, the work in this chapter addressed questions about the reactions and enzyme 
functions in the phenanthrene catabolic pathway of M. vanbaalenii PYR-1. The major findings are 
1) the identification of PhdF as the ring-cleaving dioxygenase; 2) the identification of PhdG as the 
hydratase-aldolase; and 3) the absence of an isomerase within the phenanthrene catabolic route 
beginning with 3,4-dihydroxyphenanthrene. The work also showed that the ring-cleaving 
dioxygenase reaction within the catabolic pathway beginning with 9,10-dihydroxyphenanthrene 
must be catalyzed by an enzyme other than PhdF. Dioxygenases capable of cleaving 1,2-
dihydroxyphenanthrene were identified, but the genes encoding these dioxygenases are not 
upregulated in the presence of PAHs and the hydratase-aldolase that is upregulated in the presence 
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of PAHs does not cleave the dioxygenase product. The results here support but do not confirm the 




3,4-Dihydroxyphenanthrene Synthesis (19) 
5,6-Dimethoxyisobenzofuran-1(3H)-one was synthesized from 3,4-dimethoxybenzoate 
following a published procedure (von Kleist, 2016) (step i). Benzylic bromination and hydrolysis 
converts 5,6-dimethoxyisobenzofuran-1(3H)-one to a mixture of 2-formyl-4,4-dimethoxybenzoic 
acid and 3-hydroxy-5,6-dimethoxyisobenzofuran-1(3H)-one (Nandakumar, 2013) (step ii). A 
Haworth methylation was used to synthesize methyl 2-formyl-4,5-dimethoxybenzoate (step iii). A 
Wittig reaction using the reagent benzyltriphenylphosphonium bromide and potassium tert-
butoxide was used to synthesize methyl-4,5-dimethoxy-2-styrylbenzoate (step iv). 
Photocyclization using iodine and radiation synthesized methyl 3,4-dimethoxyphenanthrene-1-
carboxylate (Pampin, 2003) (step v). Ester hydrolysis using NaOH followed by acidification 
produced 3,4-dimethoxyphenanthrene-1-carboxylic acid (step vi). Decarboxylation using copper 
in quinoline produced 3,4-dimethoxyphenanthrene (step vii). 1H and 13C NMR spectroscopy were 
used to confirm the identity of this compound. This stable compound was stored at -20 C°. When 
needed, small amounts of 3,4-dimethoxyphenanthrene were hydrolyzed under argon to 3,4-
dihydroxyphenanthrene using boron tribromide (step viii).  3,4-Dimethoxyphenanthrene: 1H NMR 
(CDCl3, 300 MHz) δ 4.0 (s, 1H), 4.1 (s, 1H), 7.4 (d, 1H J = 8.7 Hz), 7.6 (m, 5H), 7.9 (dd, 1H, J = 
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1.8 Hz, 7.7 Hz), 9.7 (dd, 1H J = 0.9 Hz, 8.2 Hz); 13C NMR (CDCl3, 75 MHz) δ 56.5, 59.7, 113.0, 
124.6, 124.8, 125.5, 126.48, 120.51, 126.9, 127.9, 128.26, 128.33, 129.6, 133.0, 147.1, 151.5  
 
Scheme 3.7: Synthesis of 3,4-dihydroxyphenanthrene. 
 
1,2-Dihydroxyphenanthrene (20) and 2,3-Dihydroxyphenanthrene Synthesis 
Synthesis of 1,2-dihydroxyphenanthrene and 2,3-dihydroxyphenanthrene began with 2,3-
dimethoxybenzaldehyde and 3,4-dimethoxybenzaldehyde, respectively, and followed steps iv-viii 
described above for the synthesis of 3,4-dihydroxyphenanthrene.   1,2-Dimethoxyphenanthrene: 
1H NMR (CDCl3, 400 MHz) δ 4.02 (s, 3H), 4.04 (s, 3H), 7.37 (d, 1H, J = 9.1 Hz), 7.54 (m, 1H), 
7.62 (m, 1H), 7.74 (d, 1H, J = 9.1 Hz). 7.86 (dd, 1H, J = 1.4 Hz, 7.8 Hz), 8.09 (dd, 1H, J = 0.5 Hz, 
9.1 Hz), 8.42 (d, 1H, J = 9.0 Hz), 8.59 (dd, 1H, J = 0.5 Hz, 8.2 Hz); 13C NMR (CDCl3, 75 MHz) δ 
56.4, 61.3, 113.4, 118.9, 120.2, 122.3, 125.4, 125.9, 126.7, 127.36, 127.41, 128.6, 130.3, 131.0, 
143.8, 149.8. 2,3-Dimethoxyphenanthrene: 1H NMR (CDCl3, 500 MHz) δ 4.08 (s, 3H), 4.16 (s, 
3H), 7.28 (s, 1H), 7.57 (m, 1H), 7.65 (m, 1H), 7.69 (m, 1H), 7.91 (d, 1H, J = 7.9 Hz), 8.05 (s, 1H), 
8.57 (d, 1H, J = 8.3 Hz); 13C NMR (CDCl3, 125 MHz) δ 55.9, 56.0, 103.3, 108.3, 122.1, 124.9, 
125.3, 125.6, 126.0, 126.2, 127.2, 128.7, 129.8, 131.4, 149.33, 149.35. 
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Scheme 3.8: Synthesis of 1,2-dihydroxyphenanthrene and 2,3-dihydroxyphenanthrene. 
 
9,10-Dihydroxyphenanthrene (18) Synthesis 
9,10-Phenanthrene quinone was converted to phenanthrene-9,10-diyl diacetate by 
following a published procedure (Langvik, 2015). 1H and 13C NMR spectroscopy were used to 
confirm the identity of this compound. This stable compound was stored at -20 C°. When needed, 
small amounts of phenanthrene-9,10-diyl diacetate were hydrolyzed under argon to 9,10-
dihydroxyphenanthrene using acetyl chloride and ethanol.  Phenanthrene-9,10-diyl diacetate: 1H 
NMR (CDCl3, 300M Hz) δ 2.5 (s, 6H), 7.7 (m, 4H), 7.9 (m, 2H), 8.7 (d, 2H, J = 8.5 Hz); 
13C NMR 
(CDCl3, 75 MHz) δ 20.5, 122.0, 123.0, 126.5, 127.1, 127.3, 129.7, 135.8, 168.2 
 
Scheme 3.9: Synthesis of 9,10-dihydroxyphenanthrene. 
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Chapter 4: Investigation of the Ring-Cleaving Dioxygenase and Hydratase-




Pyrene is a high molecular weight (HMW) PAH with a four-ring aromatic structure 
(Scheme 4.1) that causes various toxicities such as oxidative stress in the liver of goldfish, 
abnormal cardiac development in zebrafish, abnormal behavior and neural development in 
pufferfish larvae, and hepatotoxicity in mice (Sun, 2008; Zhang, 2012; Sugahara, 2014; Zhang, 
2015). While pyrene does not act as a carcinogen, the structure of pyrene is similar to some HMW 
PAHs that display carcinogenic properties, such as benzo[a]pyrene, indeno[1,2,3-cd]pyrene, and 
1-nitropyrene, and elucidation of the catabolic pathway for pyrene might give insights into the 
catabolic pathways for these carcinogenic HMW PAHs. Flouranthene is another HMW PAH 
composed of naphthalene and benzene fused with a five-membered ring (Scheme 4.2). Toxicities 
caused by exposure to fluoranthene include genotoxicity by DNA strand breakage and adduct 
formation in rats, behavioral toxicity as demonstrated by suppressed motor activity in rats, reduced 
weight and growth rate in moth larvae, and inhibition of germination and growth of wheat (Vaca, 
1992; Saunders, 2003; Mrdakovic, 2015; Tomar, 2015;).  
 
Mycobacterium vanbaalenii PYR-1 can completely degrade pyrene and fluoranthene to 
carbon dioxide and water but cannot use either as the sole carbon source (Heitkamp, 1988). 
Metabolomic, proteomic, and genomic analysis elucidated catabolic pathways for both pyrene and 
fluoranthene in M. vanbaalenii PYR-1 (Kim, 2007; Kweon, 2007). The isolation and identification 
of 13 and 28 metabolic intermediates during growth of M. vanbaalenii PYR-1 in the presence of 
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pyrene and fluoranthene, respectively, allowed the formulation of potential catabolic routes for 
each (Scheme 4.1 and 4.2) (Heitkamp, 1988; Kim, 2005; Kweon, 2007). Proteins that are 
upregulated in the presence of either compound were identified using one-dimensional gel 
electrophoresis coupled with liquid-chromatography-mass spectrometry and comparison with a 
control. The genes encoding the upregulated proteins were determined using genomic analysis 
(Table 4.1). Many of the genes that are upregulated in the presence of pyrene are in the aromatic 
catabolic gene regions (Figure 4.1) and are not expressed in the control sample showing that the 
genes for aromatic catabolism are tightly regulated (Kim, 2007). Analysis of the genomic context 
of the upregulated genes and comparison of upregulated gene products to enzymes with known 
functions were used to tentatively annotate enzymes in the proposed catabolic pathways for pyrene 













Table 4.1: Proteins upregulated in M. vanbaalenii PYR-1 in the presence of pyrene or fluoranthene 













Information storage and processing Translation 3 6
Transcription 10 5
DNA replication 5 6
Cellular processes Cell wall or membrane biogenesis 5 3
Translation modification 2 3
Intracellular trafficking 1 0
Inorganic ion transport and metabolism 5 1
Signal transduction 5 4
Metabolism Energy production 11 11
Carbohydrate metabolism 9 9
Aromatic compound degradation 25 10
Amino acid metabolism 13 10
Nucleotide metabolism 2 4
Coenzyme metabolism 7 6
Lipid metabolism 15 14
Secondary metabolites 2 3
Other categories General function only 7 13
Function unknown 5 6
Uncategorized 10 3
No. of proteins upregulated by 






Figure 4.1: PAH catabolic gene regions in M. vanbaalenii PYR-1. Arrows indicate the direction 
of transcription. Numbers indicate the gene location. Bold numbers indicate genes expressed in 
the presence of pyrene or fluoranthene. Arrows are colored as follows: red: PAH catabolism, pink: 
transcriptional regulation, yellow: DNA mobilization, green: membrane transport system, blue: 














Scheme 4.1: Pyrene catabolism by M. vanbaalenii PYR-1. Brackets indicate compounds that were 
not isolated. The numbers above each arrow represent the gene location for the enzyme proposed 
to catalyze that reaction. Enzymes discussed in this chapter are written below the arrows. (Adapted 






Pyrene degradation begins with oxygenation at C-1 and C-2 (2) or C-4 and C-5 (1) followed 
by dehydrogenation to aromatize the ring (3 and 36, respectively) (Scheme 4.1). 1,2-
Dihydroxypyrene (3) enters a peripheral detoxification pathway that methylates both oxygens to 
form 4, which can be eliminated from the bacteria. 4,5-Dihydroxypyrene (36) is cleaved at the 
intradiol position by a ring-cleaving dioxygenase to produce 37 that is decarboxylated to yield 38. 
Two hydroxyl groups are added (39), a carboxylate group is removed, and dehydrogenation results 
in aromatization. The resulting compound, 3,4-dihydroxyphenanthrene (19), is further degraded 
by the route described in Chapter 3 (Scheme 3.2). The enzymes proposed for every reaction in the 
degradation of pyrene to phthalate are upregulated in the presence of pyrene compared to a control 
(Kim, 2007). Analysis of the PAH metabolic gene clusters suggests M. vanbaalenni PYR-1 
degrades phthalate through the ß-ketoadipate pathway (Stingley, 2004; Kim, 2008). The genes 
required for ß-ketoadipate catabolism are all found within the catabolic gene clusters except for ß-



























































































































































Degradation of fluoranthene begins with hydroxylation at positions C-1 and C-2, C-2 and 
C-3, or C-7 and C-8 followed by dehydrogenation to produce the dihydroxylated aromatic 
compounds 40, 41, and 42, respectively (Scheme 4.2). The resulting dihydroxyfluoranthenes can 
be methylated and removed from the cell (not shown) or cleaved by a ring-cleaving dioxygenase 
at either the intradiol (41 to 44 or 42 to 45) or the extradiol position (40 to 43 or 42 to 46). A 
hydratase-aldolase is proposed to catalyze a hydration reaction followed by retro-aldol fission of 
the cleavage products converting 43 to 47, 44 to 48, 45 to 49, and 46 to 50. Further processing is 
shown in Scheme 4.2. The pathways ultimately converge to the common intermediate phthalate 
and proceed through the ß-ketoadipate catabolic pathway.  
 
The fluoranthene catabolic pathway by M. vanbaalenii PYR-1 is not as well understood as 
other PAH catabolic pathways because the intermediate compounds are more complex and could 
be processed through several different reactions. Moreover, many of the proposed intermediates 
are structural isomers that could not be unequivocally identified. For example, a compound 
matching the molecular weight of the isomers 40, 41, and 42 was isolated, but the individual 
isomers were not separated and therefore their identity could not unequivocally established 
(Kweon, 2007). Similarly, a compound matching the molecular weight of a monohydroxylated 
fluoranthene was identified, but the location of the hydroxyl group was not determined and no 
intermediates in a catabolic pathway for this compound were identified (Kweon, 2007). Enzymes 
have not been annotated for all the transformation in the fluoranthene catabolic pathway because 
some of the proposed enzymes are expressed, but not upregulated when M. vanbaalenii PYR-1 is 
grown in the presence of fluoranthene. For example, the degradation pathway for 2,3-
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dihydroxyfluoranthene (41) is shown in Scheme 4.3. The enzymes putatively assigned to each 
reaction are given above the reaction arrows and those that are upregulated in the presence of 
fluoranthene are shown in bold. Of the 16 enzymes required to convert 41 to TCA cycle 
intermediates, only three are upregulated in M. vanbaalenii PYR-1 in the presence of fluoranthene 
(Kweon, 2007). Assaying pure enzymes with their proposed intermediates and identifying the 
reaction products would be a major step in confirming the proposed reactions and correctly 
annotating the enzymes. 
 
Scheme 4.3: Catabolism of 2,3-dihydroxyfluoranthene by M. vanbaalenii PYR-1. The numbers 
above each arrow represent the gene location for the enzyme proposed to catalyze that reaction. 
The numbers in bold are upregulated in the presence of fluoranthene. Enzymes discussed in this 
chapter are written below the arrows. (Adapted from Kweon, 2007) 
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There are several published studies identifying the ring-hydroxylating oxygenase (RHO) 
systems responsible for the initial step in the catabolism of HMW PAHs catabolized by M. 
vanbaalenii PYR-1.  Specifically, the NidA, NidA3, and PdoA systems have been assigned to the 
initial oxidation step for pyrene, fluoranthene, and phenanthrene, respectively, although the 
substrate specificities for each are not stringent and all three systems can process all three 
compounds (Kim 2006; Kweon, 2010, Kweon, 2014). While there has been much attention 
directed towards identifying the enzyme responsible for catalysis of the initial dioxygenase 
reaction, little information is available regarding the ring-cleaving and hydratase-aldolase 
reactions. We are interested in identifying the enzymes that catalyze these reactions in both the 
pyrene and fluoranthene catabolic pathways. The cupin superfamily ring-cleaving dioxygenase 
PhdI, the type I extradiol dioxygenase PhdF, and the hydratase-aldolases PhdJ and PhdG are 
upregulated in M. vanbaalenii PYR-1 when grown in the presence of pyrene. In the presence of 
fluoranthene these four enzymes are constitutively expressed but only PhdF is upregulated. We 
are also interested in determining the cleavage sites for the ring-cleaving reactions. Previous 
studies have shown that 3 can be cleaved at the meta position rather than methylated and removed 
from the cell and that 36 can be cleaved at the meta position as well as the ortho position (Scheme 
4.4) (Walter, 1991).   
 
In this chapter, we assayed PhdF and three other annotated type I extradiol dioxygenases 
(products of genes 0545, 2891, and 4413) for activity with the dihydroxypyrenes 3 and 36, and the 
dihydroxyfluoranthenes 41, and 42 (Scheme 4.4). Their reactions with 40 could not be examined 
because 40 is not yet available. We assayed PhdG for activity with the products of any successful 
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ring-opening reactions. If the extradiol dioxygenases PhdF, 0545, 2891 or 4413 did not catalyze 
the expected reactions then PhdI, the other ring-cleaving dioxygenase upregulated in the presence 
of pyrene, was assayed for activity with the same compounds. If PhdG did not process the ring-
cleavage products then PhdJ, the other hydratase-aldolase upregulated in the presence of pyrene, 





Scheme 4.4: Possible ring-cleavage and subsequent hydratase-aldolase reactions for A) 






4.2 Experimental Procedures 
Materials  
Chemicals, biochemicals, buffers, and solvents were purchased from Sigma-Aldrich 
Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), Fluka Chemical Corp. 
(Milwaukee, WI), or EMD Millipore, Inc. (Billerica, MA). 1-Hydroxypyrene, pyrene-4,5-dione, 
fluoranthene, 1-hydroxynaphthalene, and 4-bromo-2-methoxy-1-methylbenzene were purchased 
from Sigma-Aldrich Chemical Co. The synthetic procedures for 1,2-dihydroxypyrene, 4,5-
dihydroxypyrene, 1,2-dihydroxyfluoranthene, 2,3-dihydroxyfluoranthene, and 7,8-
dihydroxyfluoranthene are reported in the supplemental material (Section 4.5). The Sephadex G-
100 resin was obtained from GE Healthcare (Piscataway, NJ). The EconoColumn® 
chromatography columns were obtained from BioRad (Hercules, CA). 
 
General Methods 
Protein concentrations were determined using the Bradford method (Bradford, 1976). 
Electrospray ionization mass spectrometry (ESI-MS) was carried out on an LCQ electrospray ion-
trap mass spectrometer (Thermo, San Jose, CA) housed in the ICMB Protein and Metabolite 
Analysis Facility at the University of Texas. Steady-state kinetic assays were performed on an 
Agilent 8453 diode-array spectrophotometer (Agilent Technologies, Santa Clara, CA). Nonlinear 
regression data analysis was performed using the program Grafit (Erithacus Software Ltd., Staines, 
U.K.). Nuclear magnetic resonance (NMR) spectra were recorded on a Varian UNITY+ 300 MHz 
(Palo Alto, CA) or a Bruker AVANCE III 500 MHz spectrometer (Billerica, MA). NMR signals 
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were analyzed using the software program SpinWorks 3.1.6 (Copyright 2009 Kirk Marat, 
University of Manitoba). 
 
Enzymes 
The purified dioxygenases PhdI and PhdF and the hydratase-aldolases PhdJ and PhdG were 
prepared as described in Chapter 2. The purified dioxygenases designated 2891, 4413, and 5306 
were prepared as described in Chapter 3.  
 
Activity Assays 
Reactions of Dioxygenases with 1,2-Dihydroxypyrene (3) and 4,5-Dihydroxypyrene (36) 
Aliquots of the purified dioxygenase enzymes PhdI, PhdF, and those designated 2891, 
4413, or 5306 (1 – 15 µL, 5 – 100 nM final) and 1,2-dihydroxypyrene or 4,5-dihydroxypyrene in 
ethanol (1 µM – 1 mM final) were added to 20 mM HEPES buffer at pH 7.0 (1 mL) and the 
reactions monitored using UV spectroscopy. No change in absorbance other than that caused by 
non-enzymatic oxidation was observed using any dioxygenase.  
 
Reactions of Dioxygenases with 1,2-Dihydroxyfluoranthene (40), 2,3-Dihydroxyfluoranthene (41), 
and 7,8-Dihydroxyfluoranthene (42) 
Aliquots of the purified dioxygenase enzyme PhdI, PhdF, and those designated 2891, 4413, 
or 5306 (1 – 15 µL, 5 – 100 nM final) and 1,2-dihydroxyfluoranthene 2,3-dihydroxyfluoranthene 
or 7,8-dihydroxyfluoranthene in ethanol (1 µM – 1 mM final) were added to 20 mM HEPES buffer 
at pH 7.0 (1 mL) and the reactions monitored using UV spectroscopy. No change in absorbance 
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other than that caused by non-enzymatic oxidation was observed using any dioxygenase with 2,3-
dihydroxyfluoranthene. No change in absorbance other than that caused by non-enzymatic 
oxidation was observed using PhdI, 2891 or 5306 with 7,8-dihydroxyfluoranthene. Reactions 
using PhdF or 4413 with 7,8-dihydroxyfluoranthene showed spectral shifts consistent with 
enzymatic activity.  
 
Reactions of a Hydratase-Aldolase with 46 
A coupled assay was used to follow the reaction of PhdG with the ring-opened product 
generated from 7,8-dihydroxyfluoranthene using PhdF. The reactions were initiated by adding 100 
µl of PhdF supernatant prepared as described in Chapter 2 and various concentrations of 7,8-
dihydroxyfluoranthene (1 µM – 1 mM final) in ethanol to 1 ml of 20 mM HEPES buffer at pH 7.0. 
The reactions were monitored by following the increase in absorbance of the product at 488 nm 
until completion as determined by no further change in absorbance. Upon completion, aliquots of 
PhdG (0.1 - 1 µM final) prepared as described in Chapter 2 were added. No change in absorbance 
was observed.  
 
Product Identification 
Reaction of PhdF with 7,8-Dihydroxyfluoranthene (42) 
PhdF was used to generate the ring-opened product of 7,8-dihydroxyfluoranthene (7,8-
DHF) and the product was identified by UV spectroscopy, derivatization, and NMR spectroscopy. 
After expression of PhdF as described in Chapter 2, the cells were centrifuged at 17,700 × g for 
30 min. The cell pellet was washed 3 times by resuspension in 5 mM sodium phosphate at pH 7.0 
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(OD600 = 0.5 for 10 µL suspension in 1 mL buffer) and then centrifuged (17,700 × g for 30 min). 
The pellet was then resuspended in 5 mM sodium phosphate at pH 7.0 (OD600 = 0.5 for 10 µL 
PhdF in 1 mL of buffer) to a final volume of 10 mL. A solution of 7,8-DHF in ethanol (67 mg/mL 
stock concentration) was added to the cell suspension, which was stirring on ice, over the course 
of 5 min. Aliquots (500 uL) were removed every 5 min, centrifuged at 20,800 × g for 2 min, and 
the cell free supernatant monitored by UV spectroscopy until the reaction was complete (~30 min), 
as determined by no further change in absorbance at 488 nm.  The reaction was centrifuged at 
17,700 x g for 20 min and the pH of the cell-free solution adjusted to 8.0 using drops of 1M NaOH. 
The solution was washed using 2.5 volumes of ethyl acetate. The aqueous layer was collected and 
concentrated to 600 µL and loaded onto a Sephadex G-100 column. The column was washed with 
water and the eluate monitored using UV spectroscopy (488 nm). The product-containing fractions 
(~6 mL) were combined and evaporated to dryness. The product was analyzed using ESI-MS. The 
product was resuspended in ~0.6 mL of CDCl3 and placed in an NMR tube. A 
1H NMR spectrum 
of the crude product is consistent with the structure of 46. Once more compound is available, 1H 
NMR and 13C NMR spectroscopic analysis will be used to identify the product(s).  
 
Scheme 4.5: Compound 46 was generated as described in the text. It is anticipated that 46 can be 




Steady-State Kinetic Analysis  
Reactions with 7,8-Dihydroxyfluoranthene (42) 
An aliquot of PhdF (15 µL) prepared as described in Chapter 2 or 4413 (6 µL), prepared 
as described in Chapter 3, was added to 1 mL of 20 mM HEPES at pH 7.0 to give a final 
concentration of 200 nM for PhdF and 140 nM for 4413. Assays were initiated by the addition of 
aliquots of a stock solution of 7,8-dihydroxyfluoranthene in ethanol (20 mM). The final substrate 
concentration ranged from 1 – 30 µM for PhdF reactions and 3 – 300 µM for 4413 reactions. The 
reaction was monitored by following an increase in absorbance at 488 nm (ε = 5490 M−1 cm−1). 
Initial rates were determined from the first 30 s of the reaction, plotted versus substrate 
concentration, and fit to the substrate inhibition or Michaelis-Menten equation to calculate the 
steady-state parameters kcat, KM, and Ki using Grafit (Johnson, 2011; Haldane, 1930). 
 
4.3 Results and Discussion 
Reactions with Pyrenes 
Activity Assays using Dioxygenases with 1,2-Dihydroxypyrene (3) and 4,5-Dihydroxypyrene (36) 
All five dioxygenase enzymes were assayed for activity with 1,2-dihydroxypyrene (3) and 
4,5-dihydroxypyrene (36). When 1,2-dihydroxypyrene (3) or 4,5-dihydroxypyrene (36) was 
incubated with each enzyme for >30 min no spectral changes were observed suggesting that these 
compounds might not be substrates for any of the five enzymes. The absorbance spectrums for 








Figure 4.2: Absorbance spectrum of A) 1,2-dihydroxypyrene without enzyme and B) 4,5-
dihydroxypyrene without enzyme.  
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Reactions with Fluoranthenes 
Activity Assays using Dioxygenases with 1,2-Dihydroxyfluoranthene (40), 2,3-
Dihydroxyfluoranthene (41), and 7,8-Dihydroxyfluoranthene (42) 
All five dioxygenase enzymes were assayed for activity with 1,2-dihydroxyfluoranthene 
(40), 2,3-dihydroxyfluoranthene (41), and 7,8-dihydroxyfluoranthene (42). When 2,3-
dihydroxyfluoranthene (41) was incubated with each enzyme for >30 min no spectral changes 
were observed suggesting that this compound might not be a substrate for any of the five enzymes. 
The absorbance spectrum for 2,3-dihydroxyfluoranthene (41) without enzyme is given in Figure 
4.3. When 7,8-dihydroxyfluoranthene was incubated with PhdI, 2891 or 5306 for >30 min no 
spectral changes were observed suggesting that 7,8-dihydroxyfluoranthene might not be a 
substrate for PhdI, 2891 or 5306. 7,8-Dihydroxyfluoranthene was processed by PhdF and 4413 
and the absorbance spectra for the reaction with PhdF is shown in Figure 4.4.  
Figure 4.3: Absorbance spectrum for 2,3-dihydroxyfluoranthene without enzyme. 
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Figure 4.4: Absorbance spectra for the reaction of PhdF and 7,8-dihydroxyfluoranthene (42). The 
structure of 46 was inferred from a 1H NMR spectrum of the crude reaction product. The 
compound will be unequivocally characterized in future work.  
 
Identification of Dioxygenase Reaction Products 
To determine whether cleavage of 7,8-dihydroxyfluoranthene (42) occurs at the ortho or 
meta position the product of the PhdF-catalyzed reaction was isolated and identified. 7,8-
Dihydroxyfluoranthene (42) was treated with a whole cell suspension of PhdF. The structure of 46 
was inferred from a 1H NMR spectrum of the crude reaction product. It appears that PhdF and 
4413 catalyze the ring-opening of 7,8-dihydroxyfluoranthene (42) at the meta position and the 
product is in the cis form as shown in Scheme 4.5. The compound will be further characterized in 
when more compound can be obtained. 
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Steady-State Kinetic Analysis Using Dioxygenases   
The kobs vs substrate concentration was plotted for the reactions of PhdF and 4413 with 
7,8-dihydroxyfluoranthene (42) and are shown in Figure 4.5. The reaction using PhdF displays 
substrate inhibition and the data are fit using the substrate inhibition equation (Haldane, 1930). 
The reaction using 4413 appears to obey classic Michaelis-Menten kinetics and the data are fit 
using the Michaelis-Menten equation (Johnson, 2011). The measured kcat/KM for PhdF with 7,8-
dihydroxyfluoranthene is nearly an order of magnitude greater than for the reaction using 4413. 
Kinetic parameters are summarized in Table 4.2. 
 
Figure 4.5: Plots of kobs vs 7,8-dihydroxyfluoranthene concentration for the reaction with A) PhdF 
or B) 4413. The data are fit to the substrate inhibition or Michaelis-Menten equation (Haldane, 




Table 4.2: Kinetic parameters for the reaction of PhdF and 4413 with 7,8-dihydroxyfluoranthene.  
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Activity Assays using PhdG with 46 
A coupled assay with PhdF, 7,8-dihydroxyfluoranthene (42), and PhdG was used to 
determine if PhdG can cleave the ring-opened product 46.  After 46 was generated using PhdF and 
7,8-dihydroxyfluoranthene (42), PhdG was added. No spectral changes were observed. This 
suggests that 46 might not be a substrate for PhdG.  
 
Summary 
Overall, the work in this chapter addressed questions about the reactions and enzyme 
functions in the pyrene and fluoranthene catabolic pathways of M. vanbaalenii PYR-1. The major 
findings are 1) none of the dioxygenases assayed (designated PhdF, PhdI, 2891, 4413, and 5306) 
can ring-cleave the proposed pyrene catechol intermediates 3 or 36 or the proposed fluoranthene 
catechol intermediate 41; 2) the dioxygenases designated PhdF and 4413 catalyze extradiol ring-
cleavage of the fluoranthene catechol compound 42 to produce 46; and 3) PhdG does not process 
46 (see Scheme 4.4).  
 
The inability of PhdF to catalyze ring-cleavage of either pyrene catechol compound (3 or 
36, Scheme 4.4) is not surprising. During degradation of pyrene by M. vanbaalenii PYR-1, 
intermediate 3 is not ring-cleaved even though PhdF is upregulated in the presence of pyrene. 
However, 36 is cleaved at the ortho position, a reaction that the extradiol dioxygenase PhdF likely 
cannot catalyze (Kim, 2007). Three other annotated type I extradiol dioxygenases (designated 
2891, 4413, and 5306) and one annotated as a type III extradiol dioxygenase (PhdI)  were also 
unable to ring-cleave 3 or 36. There are three other annotated type I extradiol dioxygenases in M. 
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vanbaalenii PYR-1 and one of these may have the ability to meta ring-cleavage of 3, although 
none of these are upregulated in M. vanbaalenii PYR-1 in the presence of pyrene (Kim, 2008; 
Kim, 2007). The only intradiol dioxygenase that has been identified thus far in M. vanbaalenii 
PYR-1 is protocatechuate 3,4-dioxygenase (Kim, 2008). It is possible that this enzyme is 
responsible for the ortho cleavage of 36. Future work on the reaction of protocatechuate 3,4-
dioxygenase with 36 can clarify the issue.   
 
None of the annotated type I extradiol dioxygenases (designated PhdF, 2891, 4413, 5306) 
or the annotated type III extradiol dioxygenase (PhdI) can ring-cleave the fluoranthene catabolic 
intermediate 41. However, the dioxygenases designated PhdF and 4413 can cleave the 
fluoranthene catabolic intermediate 42 at the meta position to produce 46 (Scheme 4.4). The 
hydratase-aldolase PhdG does not process 46. It is likely that an isomerization of 46 to the open 
trans form (Scheme 4.4) must take place before hydration and retro-aldol cleavage by PhdG can 
occur. This isomerization may happen non-enzymatically in the cellular environment of M. 
vanbaalenii PYR-1. There may also be an isomerase within M. vanbaalenii PYR-1 that has not 
yet been identified that can catalyze the isomerization of 46. There are three other annotated type 
I extradiol dioxygenases in M. vanbaalenii PYR-1 (Kim, 2008). Although none of these 
dioxygenases are upregulated in the presence of fluoranthene, one of these may be able to catalyze 
both the ring-cleavage of 42 and the isomerization of 46 (Kweon, 2007). We are currently 
attempting to synthesize the proposed fluoranthene catechol intermediate 40. We will investigate 
the activities of the dioxygenases described in this chapter (designated PhdI, PhdF, 2891, 4413, 
and 5306) with 40 as soon as the compound is available.  
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4.5 Supplemental 
1,2-Dihydroxypyrene (3) and 4,5-Dihydroxypyrene (36) Synthesis 
Oxidation of 1-hydroxypyrene to pyrene-1,2-dione was performed by following a 
published procedure (Wu, 2010). Esterification of pyrene-1,2-dione and pyrene-4,5-dione to 
pyrene-1,2-diyl diacetate and pyrene-4,5-diyl diacetate, respectively, were performed by following 
published procedures (Langvik, 2015). 1H and 13C NMR spectroscopy were used to verify the 
identity of these compounds. These stable compounds were stored at -20 °C. When needed, small 
amounts of the diacetates were hydrolyzed under argon to 1,2-dihydroxypyrene or 4,5-
dihydroxypyrene using acetyl chloride and ethanol.  
Pyrene-1,2-diyl diacetate: 1H NMR ((CD3)2CO, 500 MHz) δ 1.6 (s, 3H), 2.6 (s, 3H), 7.4 (d, 1H, J 
= 9.2 Hz), 8.0 (d, 1H, J = 9.3 Hz), 8.1 (m, 1H), 8.3 (d, 2H, J = 8.9 Hz), 8.37 (s, 1H), 8.41 (m, 2H); 
13C NMR ((CD3)2CO, 125 MHz) δ 19.9, 20.5, 121.3, 124.0, 124.7, 124.9, 126.1, 126.2, 127.2, 
127.3, 127.7, 129.1, 130.18, 130.21, 131.6, 131.8, 138.0, 141.1, 168.4, 139.5. 
Pyrene-4,5-diyl diacetate: 1H NMR (CDCl3, 400 MHz) δ 2.6 (s, 6H), 8.0 (t, 2H), 8.1 (s, 2H), 8.17 
(dd, 2H, J = 1.1 Hz, 7.9 Hz), 8.23 (dd, 2H, J = 1.1 Hz, 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 
20.6, 119.4, 123.6, 125.8, 125.9, 126.4, 127.6, 131.2, 136.7, 168.3 
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Scheme 4.6: Synthesis of A) 1,2-dihydroxypyrene and B) 4,5-dihydroxypyrene. 
 
2,3-Dihydroxyfluoranthene (41) Synthesis 
Fluoranthen-3-yl acetate was synthesized from fluoranthene following a published 
procedure (Shenbor, 1969). Transesterification using ethanol and acetyl chloride produced 3-
hydroxyfluoranthene. Synthesis of 2,3-dihydroxyfluoranthene from 3-hydroxyfluoranthene 
followed the procedure described above for 1,2-dihydroxyfluoranthene synthesis from 1-
hydroxyfluoranthene. 
Fluoranthene-2,3-diyl diacetate: 1H NMR (CDCl3, 300 MHz) δ 2.4 (s, 3H), 2.5 (s, 3H), 7.4 (m, 
2H), 7.65 (m, 1H), 7.8 (m, 5H); 13C NMR (CDCl3, 75 MHz) δ 20.5, 20.8, 116.5, 120.3, 121.4, 






Scheme 4.7: Synthesis of A) 1,2-dihydroxyfluoranthene and B) 2,3-dihydroxyfluoranthene. 
 
7,8-Dihydroxyfluoranthene (42) Synthesis 
8-Methoxy-9-methylfluoranthene was synthesized using a published procedure 
(Yamaguchi, 2016). Demethylation using boron tribromide produced 8-hydroxy-9-
methylfluoranthene. Oxidation to 9-methylfluoranthene-7,8-dione was performed following a 
published procedure (Wu, 2010). O-Methylation using dimethyl sulfate produced 7,8-dimethoxy-
9-methylfluoranthene. Benzylic bromination using N-bromosuccinimide followed by hydrolysis 
produced 7,8-dimethoxyfluoranthene-8-carbaldehyde that was oxidized to 7,8-
dimethoxyfluoranthene-8-carboxylic acid using the Jones reagent.  Decarboxylation using copper 
in quinoline afforded 7,8-dimethoxyfluoranthene. 1H and 13C NMR spectroscopy were used to 
verify the identity of this compound. This stable compound was stored at -20 °C. When needed, 
small amounts of 7,8-dimethoxyfluoranthene were hydrolyzed under argon to 9,10-
dihydroxyfluoranthene using boron tribromide.  
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7,8-dimethoxyfluoranthene: 1H NMR (CDCl3, 500 MHz) δ 4.0 (s, 3H), 4.1 (s, 3H), 7.0 (d, 1H, J = 
8.1 Hz), 7.6 (m, 2H), 7.7 (m, 1H), 7.8 (d, 2H, J = 8.2 Hz), 7.9 (m, 2H), 8.19 (d, 1H, J = 6.9 Hz); 
13C NMR (CDCl3, 125 MHz) δ 56.3, 60.3, 111.4, 117.3, 119.1, 123.3, 125.6, 126.4, 127.8, 128.2, 
129.9, 132.4, 132.8. 133.4, 135.4, 136.9, 146.0, 153.0.   
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